UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
   
þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended JuneSeptember 30, 2009
OR
   
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from          to          
Commission File NumberNumber: 1-13252
McKESSON CORPORATION
(Exact name of registrantRegistrant as specified in its charter)
   
Delaware
94-3207296
(State or other jurisdiction of incorporation or organization) 94-3207296
(I.R.S.IRS Employer Identification No.)
   
One Post Street, San Francisco, California 94104
(Address of principal executive offices) (Zip Code)
(415) 983-8300
(Registrant’s telephone number, including area code)
     Indicate by check mark whether the registrantRegistrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrantRegistrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yesþ Noo
     Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yesþ Noo
     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filerþ Accelerated filero Non-accelerated filero Smaller reporting companyo
    (Do not check if a smaller reporting company)  
     Indicate by check mark whether the registrant is a shell company (asas defined in Rule 12b-2 of the Exchange Act).Act. Yeso Noþ
     Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
   
Class Outstanding as of JuneSeptember 30, 2009
Common stock, $0.01 par value 266,140,008267,982,667 shares
 
 

 


 

McKESSON CORPORATION
TABLE OF CONTENTS
           
 Item Page 
 PART I. FINANCIAL INFORMATION 
Item Page
PART I. FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
        
1. Condensed Consolidated Financial Statements  Condensed Consolidated Financial Statements   
        
 Condensed Consolidated Statements of Operations
Quarter ended June 30, 2009 and 2008
 3    3 
        
 Condensed Consolidated Balance Sheets
June 30, 2009 and March 31, 2009
 4    4 
        
 Condensed Consolidated Statements of Cash Flows
Quarter ended June 30, 2009 and 2008
 5    5 
        
 Financial Notes 6    6 
        
 Management’s Discussion and Analysis of Financial Condition and Results of Operations 20    22 
        
 Quantitative and Qualitative Disclosures About Market Risk 29    32 
        
 Controls and Procedures 29    32 
        
 PART II. OTHER INFORMATION 
PART II. OTHER INFORMATION
PART II. OTHER INFORMATION
   
        
 Legal Proceedings 29    32 
        
 Risk Factors 29    32 
        
 Unregistered Sales of Equity Securities and Use of Proceeds 29    33 
        
 Defaults Upon Senior Securities 30    33 
        
 Submission of Matters to a Vote of Security Holders 30    34 
        
 Other Information 30    35 
        
 Exhibits 30    35 
        
 Signatures 30    35 
EX-10.1 EX-10.1 EX-10.1
EX-31.1 EX-31.1 EX-31.1
EX-31.2 EX-31.2 EX-31.2
EX-32 EX-32 EX-32
EX-101 INSTANCE DOCUMENT EX-101 INSTANCE DOCUMENT EX-101 INSTANCE DOCUMENT
EX-101 SCHEMA DOCUMENT EX-101 SCHEMA DOCUMENT EX-101 SCHEMA DOCUMENT
EX-101 CALCULATION LINKBASE DOCUMENT EX-101 CALCULATION LINKBASE DOCUMENT EX-101 CALCULATION LINKBASE DOCUMENT
EX-101 LABELS LINKBASE DOCUMENT EX-101 LABELS LINKBASE DOCUMENT EX-101 LABELS LINKBASE DOCUMENT
EX-101 PRESENTATION LINKBASE DOCUMENT EX-101 PRESENTATION LINKBASE DOCUMENT EX-101 PRESENTATION LINKBASE DOCUMENT
EX-101 DEFINITION LINKBASE DOCUMENT EX-101 DEFINITION LINKBASE DOCUMENT EX-101 DEFINITION LINKBASE DOCUMENT

2


McKESSON CORPORATION
PART I. FINANCIAL INFORMATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except per share amounts)
(Unaudited)
                
         Quarter Ended Six Months Ended 
 Quarter Ended June 30,  September 30, September 30, 
 2009 2008  2009 2008 2009 2008 
Revenues $26,657 $26,704  $27,130 $26,574 $53,787 $53,278 
Cost of Sales 25,354 25,436  25,795 25,272 51,149 50,708 
              
Gross Profit 1,303 1,268  1,335 1,302 2,638 2,570 
Operating Expenses 844 897  888 921 1,732 1,818 
Litigation Credit  (20)   (20)  
              
Total Operating Expenses 868 921 1,712 1,818 
Operating Income 459 371  467 381 926 752 
Other Income, Net 10 21  4 33 14 54 
Interest Expense  (48)  (34)  (47)  (35)  (95)  (69)
              
Income Before Income Taxes 421 358  424 379 845 737 
Income Tax Expense  (133)  (123)  (123)  (52)  (256)  (175)
              
Net Income $288 $235  $301 $327 $589 $562 
              
  
Earnings Per Common Share  
Diluted $1.06 $0.83  $1.11 $1.17 $2.17 $2.00 
Basic $1.07 $0.85  $1.13 $1.19 $2.19 $2.04 
  
Dividends Declared Per Common Share $0.12 $0.12  $0.12 $0.12 $0.24 $0.24 
  
Weighted Average Shares  
Diluted 272 282  271 280 272 281 
Basic 270 277  267 275 268 276 
See Financial Notes

3


McKESSON CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In millions, except per share amounts)
(Unaudited)
               
 June 30, March 31,  September 30, March 31, 
 2009 2009  2009 2009 
ASSETS
  
Current Assets  
Cash and cash equivalents $2,644 $2,109  $3,215 $2,109 
Receivables, net 7,532 7,774  7,838 7,774 
Inventories, net 8,615 8,527  8,598 8,527 
Prepaid expenses and other 271 261  279 261 
          
Total 19,062 18,671  19,930 18,671 
 
Property, Plant and Equipment, Net 814 796  836 796 
Capitalized Software Held for Sale, Net 230 221  241 221 
Goodwill 3,549 3,528  3,560 3,528 
Intangible Assets, Net 630 661  605 661 
Other Assets 1,432 1,390  1,452 1,390 
          
Total Assets $25,717 $25,267  $26,624 $25,267 
          
  
LIABILITIES AND STOCKHOLDERS’ EQUITY
  
Current Liabilities  
Drafts and accounts payable $12,156 $11,739  $12,688 $11,739 
Deferred revenue 1,088 1,145  994 1,145 
Current portion of long-term debt 217 219  217 219 
Other accrued liabilities 2,480 2,503  2,521 2,503 
          
Total 15,941 15,606  16,420 15,606 
 
Long-Term Debt 2,292 2,290  2,294 2,290 
Other Noncurrent Liabilities 1,213 1,178  1,191 1,178 
 
Other Commitments and Contingent Liabilities (Note 11) 
Other Commitments and Contingent Liabilities (Note 12) 
 
Stockholders’ Equity  
Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding      
Common stock, $0.01 par value  
Shares authorized: June 30, 2009 and March 31, 2009 – 800 
Shares issued: June 30, 2009 – 353 and March 31, 2009 – 351 4 4 
Shares authorized: September 30, 2009 and March 31, 2009 — 800 
Shares issued: September 30, 2009 — 356 and March 31, 2009 — 351 4 4 
Additional Paid-in Capital 4,434 4,417  4,554 4,417 
Retained Earnings 6,358 6,103  6,627 6,103 
Accumulated Other Comprehensive Loss  (84)  (179)
Accumulated Other Comprehensive Income (Loss) 3  (179)
Other  (8)  (8)  (12)  (8)
Treasury Shares, at Cost, June 30, 2009 – 87 and March 31, 2009 – 80  (4,433)  (4,144)
Treasury Shares, at Cost, September 30, 2009 — 88 and March 31, 2009 — 80  (4,457)  (4,144)
          
Total Stockholders’ Equity 6,271 6,193  6,719 6,193 
          
Total Liabilities and Stockholders’ Equity $25,717 $25,267  $26,624 $25,267 
          
See Financial Notes

4


McKESSON CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
(Unaudited)
                
 Quarter Ended June 30,  Six Months Ended September 30, 
 2009 2008  2009 2008 
Operating Activities
  
Net income $288 $235  $589 $562 
Adjustments to reconcile to net cash provided by operating activities:  
Depreciation and amortization 111 106  224 218 
Deferred taxes 60 10  104 62 
Income tax reserve reversals   (65)
Share-based compensation expense 24 28  53 53 
Other non-cash items 18  (4)  (4)  (8)
Changes in operating assets and liabilities, net of business acquisitions:  
Receivables 301  (311) 51  (337)
Impact of accounts receivable sales facility  325   497 
Inventories  (42)  (272) 24  (169)
Drafts and accounts payable 356 329  811 17 
Deferred revenue  (84)  (53)  (194)  (152)
Taxes 17 62  60 48 
Other  (142)  (141)  (185)  (178)
          
Net cash provided by operating activities 907 314  1,533 548 
          
 
Investing Activities
  
Property acquisitions  (42)  (40)  (93)  (80)
Capitalized software expenditures  (44)  (38)  (96)  (90)
Acquisitions of businesses, less cash and cash equivalents acquired   (242)  (6)  (320)
Other   (42) 3 37 
          
Net cash used in investing activities  (86)  (362)  (192)  (453)
          
  
Financing Activities
  
Proceeds from short-term borrowing 5 558 
Proceeds from short-term borrowings 5 3,532 
Repayments of short-term borrowings  (6)  (558)  (6)  (3,532)
Common stock repurchases, including shares surrendered for tax withholding  (298)  (147)
Common stock transactions – other 31 35 
Common stock transactions — issuances 108 65 
Common stock share repurchases, including shares surrendered for tax withholding  (322)  (147)
Common stock share repurchases, retirements   (204)
Common stock transactions — other 16 8 
Dividends paid  (34)  (17)  (66)  (50)
Other  (1)  (1)  (2)  (1)
          
Net cash used in financing activities  (303)  (130)  (267)  (329)
 
Effect of exchange rate changes on cash and cash equivalents 17 3  32  (5)
          
Net increase (decrease) in cash and cash equivalents 535  (175) 1,106  (239)
Cash and cash equivalents at beginning of period 2,109 1,362  2,109 1,362 
          
Cash and cash equivalents at end of period $2,644 $1,187  $3,215 $1,123 
          
See Financial Notes

5


McKESSON CORPORATION
FINANCIAL NOTES
(UNAUDITED)
1.  Significant Accounting Policies
     Basis of Presentation: The condensed consolidated financial statements of McKesson Corporation (“McKesson,” the “Company,” or “we” and other similar pronouns) include the financial statements of all wholly-owned subsidiaries, majority-owned or controlled companies and certain immaterial variable interest entities (“VIEs”) of which we are the primary beneficiary. Intercompany transactions and balances have been eliminated. The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, certain information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with GAAP have been condensed.
     In accordance with the Financialapplicable sections of Accounting Standards BoardCodification (“FASB”ASC” or “Codification”) Interpretation (“FIN”) No. 46 (revised December 2003),810, “Consolidation, of Variable Interest Entities,” we evaluate our ownership, contractual and other interests in entities to determine if they are VIEs, if we have a variable interest in those entities and the nature and extent of those interests. These evaluations are highly complex and involve judgment and the use of estimates and assumptions based on available historical information and management’s estimates, among other factors.
     To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. In our opinion, these unaudited condensed consolidated financial statements include all adjustments necessary for a fair presentation of the Company’s financial position as of JuneSeptember 30, 2009, the results of operations for the quarters and six months ended September 30, 2009 and the results of operations2008 and cash flows for the quarterssix months ended JuneSeptember 30, 2009 and 2008.
     The results of operations for the quarter and six months ended JuneSeptember 30, 2009 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies and financial notes included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2009 (“2009 Annual Report”) previously filed with the SEC on May 5, 2009. Certain prior period amounts have been reclassified to conform to the current period presentation.
     The Company’s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company’s fiscal year.
     We evaluated all subsequent events that occurred after the balance sheet date through the date and time our financial statements were issued on July 28,October 27, 2009.
     Recently Adopted Accounting Pronouncements:In September 2006,On July 1, 2009, we adopted Accounting Standards Update (“ASU”) No. 2009-1, “Topic 105 — Generally Accepted Accounting Principles,” which amended ASC 105, “Generally Accepted Accounting Principles,” to establish the FASB issued StatementCodification as the source of authoritative GAAP recognized by the Financial Accounting Standards Board (“SFAS”FASB”) No. 157, “Fair Value Measurements,” which provides a consistent definitionto be applied by nongovernmental entities. Rules and interpretive releases of fair value that focuses on exit price and prioritizes the useSEC under authority of market-based inputs over entity-specific inputsfederal securities laws are also sources of authoritative GAAP for measuring fair value. SFAS No. 157 requires expanded disclosures about fair value measurements and establishes a three-level hierarchy for fair value measurements. In February 2008, the FASB issued FASB Staff Position (“FSP”) Financial Accounting Standard (“FAS”) No. 157-1, “Application of FASB Statement No. 157 to FASB Statement No. 13 and Other Accounting Pronouncements That Address Fair Value Measurements for Purposes of Lease Classification or Measurement under Statement 13,” which removes leasing from the scope of SFAS No. 157. In February 2008, the FASB also issued FSP FAS No. 157-2, “Effective Date of FASB Statement No. 157,” which permits companies to partially deferSEC registrants. On the effective date, of SFAS No. 157 for one year for nonfinancial assetsthe Codification superseded all then-existing non-SEC accounting and nonfinancial liabilities that are recognized or disclosed at fair valuereporting standards. All previous references to the superseded standards in theour consolidated financial statements have been replaced by references to the applicable sections of the Codification. The adoption of these sections did not have a material impact on a nonrecurring basis.our consolidated financial statements.

6


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
     ASC 820, “Fair Value Measurements and Disclosures,” provides a consistent definition of fair value that focuses on exit price, prioritizes the use of market-based inputs over entity-specific inputs for measuring fair value and establishes a three-level hierarchy for fair value measurements. On April 1, 2008, we adopted SFAS No. 157the applicable sections of ASC 820 for financial assets and financial liabilities and for nonfinancial assets and nonfinancial liabilities that are remeasured at least annually. At that time, we elected to defer adoption of SFAS No. 157ASC 820 for one year for nonfinancial assets and nonfinancial liabilities that are recognized or disclosed at fair value in the financial statements on a nonrecurring basis. On April 1, 2009, we adopted the provisionssections of SFAS No. 157ASC 820 regarding nonfinancial assets and nonfinancial liabilities that are recognized or disclosed at fair value in the financial statements on a nonrecurring basis. The provisionsapplicable sections of SFAS No. 157 areASC 820 were applied prospectively. The adoption of the various provisionssections of SFAS No. 157ASC 820 on April 1, 2008 and 2009 did not have a material impact on our consolidated financial statements.
     On April 1, 2009, we adopted SFAS No. 141 (revised 2007),the applicable sections of ASC 805, “Business Combinations.” SFAS No. 141(R) amends SFAS No. 141, “Business Combinations,” andASC 805 provides revised guidance for recognizing and measuring identifiable assets and goodwill acquired, liabilities assumed and any noncontrolling interest in the acquiree.acquiree in a business combination. Additionally, this SFASASC provides disclosure requirements to enable users of the financial statements to evaluate the nature and financial effects of the business combination. SFAS No. 141(R)ASC 805 amends SFAS No. 109, “Accounting for Incomethe applicable sections of ASC 740, “Income Taxes,” such that adjustments made to valuation allowances on deferred taxes and acquired tax contingencies related to acquisitions made prior to April 1, 2009 are also required to applyfall within the provisionsscope of this standard.these sections. The adoption of the applicable sections of this SFASASC did not have a material impact on our consolidated financial statements; however, the SFASASC may have an impact on the accounting for any future acquisitions or divestitures.
     On April 1, 2009, we adopted FSP No. FAS 141(R)-1, “Accountingthe applicable sections of ASC 805, “Business Combinations,” that address accounting for Assets Acquiredassets acquired and Liabilities Assumedliabilities assumed in a Business Combination That Arisebusiness combination that arise from Contingencies.” FSP No. FAS 141(R)-1 amends and clarifies SFAS No. 141(R) tocontingencies. These applicable sections address application issues raised on the initial recognition and measurement, subsequent measurement and accounting and disclosure of assets and liabilities arising from contingencies in a business combination. This FSPThese sections generally appliesapply to assets acquired and liabilities assumed in a business combination that arise from contingencies that would be within the scope of SFAS No. 5, “Accounting for Contingencies,ASC 450, “Contingencies,” if not acquired or assumed in a business combination. The adoption of this FSPthese applicable sections did not have a material impact on our consolidated financial statements; however, the FSPthese sections may have an impact on the accounting for any future acquisitions or divestitures.
     On April 1, 2009, we adopted SFAS No. 160, “Noncontrolling Interests in Consolidated Financial Statements — an amendment of ARB No. 51.ASC 810-10-65-1, “Consolidation.” This statementsection requires reporting entities to present noncontrolling interests in any of its consolidated entities as equity (as opposed to a liability or mezzanine equity) and provides guidance on the accounting for transactions between an entity and noncontrolling interests. The adoption of this SFASsection did not have a material impact on our consolidated financial statements; however, the SFASthis section may have an impact on any future investments or divestitures of our investments.
     On April 1, 2009, we adopted FSP No. FAS 142-3, “Determinationthe applicable sections of ASC 275, “Risks and Uncertainties,” and ASC 350, “Intangibles — Goodwill and Other,” that address the determination of the Useful Lifeuseful life of Intangible Assets.” FSP No. FAS 142-3 amendsintangible assets. These sections address the factors that should be considered in developing renewal or extension assumptions used to determine the useful life of a recognized intangible asset under SFAS No. 142, “Goodwill and Other Intangible Assets.”asset. The adoption of this FSPthese applicable sections did not have a material impact on our consolidated financial statements.
     On April 1, 2009, we adopted FSP No. Emerging Issues Task Force (“EITF”) 03-6-1, “Determining Whether Instruments Grantedthe applicable sections of ASC 260-10, “Earnings Per Share,” that address whether instruments granted in Share-Based Payment Transactions Are Participating Securities.” FSP No. EITF 03-6-1 concludedshare-based payment transactions are participating securities. These sections conclude that unvested share-based payment awards that contain nonforfeitable rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and shall be included in the computation of basic earnings per share pursuant to the two-class method. The adoption of this FSPthese applicable sections did not have a material impact on our consolidated financial statements.

7


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
     On April 1, 2009, we adopted EITF 08-6, “Equitythe applicable sections of ASC 323-10, “Investments — Equity Method Investment Accounting Considerations.and Joint Ventures,This EITF providesthat provide guidance on how an investor should initially measure an equity method investment, test the investment for other-than-temporary impairment and account for any subsequent equity activities by the investee. Upon adoption, this EITFthese applicable sections did not have a material impact on our consolidated financial statements.
     On April 1, 2009, we adopted EITF 08-7, “Accountingthe applicable sections of ASC 350-30, “Intangibles — Goodwill and Other: General Intangibles Other than Goodwill,” that address accounting for Defensive Intangible Assets.” This EITF providesdefensive intangible assets. These applicable sections provide guidance to situations in which an entity does not intend to actively use an acquired intangible asset but will hold (lock up) the asset to prevent others from obtaining access to the asset (a defensive intangible asset), except forexcluding intangible assets that are used in research and development activities. Upon adoption, this EITFthese applicable sections did not have a material impact on our consolidated financial statements.
     On April 1, 2009, we adopted FSP No. FAS 115-2ASC 320-10-65-1, “Investments — Debt and FAS 124-2, “Recognition and Presentation of Other-Than-Temporary Impairments.Equity Securities.” This FSPsection of the Codification revises guidance for determining how and when to recognize other-than-temporary impairments of debt securities for which changes in fair value are not regularly recognized in earnings and the financial statement presentation of such impairments. This FSPsection also expands and increases the frequency of disclosures related to other-than-temporary impairments of both debt and equity securities. Upon adoption, this FSPsection did not have a material impact on our consolidated financial statements.
     On April 1, 2009, we adopted FSP No. FAS 157-4, “Determining FairASC 820-10-65-4, “Fair Value When the VolumeMeasurements and Level of Activity for the Asset or Liability Have Significantly Decreased and Identifying Transactions That Are Not Orderly.Disclosures.FSP No. FAS 157-4This section provides additional guidance for estimating fair value in accordance with SFAS No. 157 when an asset or liability experiencedexperiences a significant decrease in volume and activity in relation to their normal market activity. Additionally, this FSPsection provides guidance on identifying circumstances that may indicate if a transaction is not orderly. Retrospective application of this FSPsection to a prior interim or annual reporting period was not permitted. The adoption of this FSPsection did not have a material impact on our consolidated financial statements.
     On June 30, 2009, we adopted FSP No. FAS 107-1 and Accounting Principles Board (“APB”) Opinion No. 28-1, “Interim DisclosuresASC 825-10-65-1, “Financial Instruments.” This section requires disclosures about Fair Value of Financial Instruments.” FSP No. FAS 107-1 and APB Opinion No. 28-1 amends SFAS No. 107, “Disclosures about Fair Value of Financial Instruments,” to require disclosures aboutthe fair value of financial instruments for interim reporting periods as well as inand annual financial statements. This FSP also amends APB Opinion No. 28, “Interim Financial Reporting,” to require those disclosures in interim financial statements. FSP No. FAS 107-1 and APB Opinion No. 28-1section does not require disclosures for earlier periods presented for comparative purposes at initial adoption. The adoption of this standardsection did not have a material impact on our consolidated financial statements. Refer to Financial Note 10,11, “Financial Instruments,” for further discussion.
     On June 30, 2009, we adopted SFAS No. 165,ASC 855-10, “Subsequent Events.” This statementASC establishes general standards of accounting and disclosures of events that occur after the balance sheet date but before financial statements are issued or are available to be issued. The adoption of this standard requiredASC requires us to evaluate all subsequent events that occurredoccur after the balance sheet date through the date and time our financial statements are issued.
     Newly Issued Accounting Pronouncements:In December 2008, the FASB issued FSP No. FAS 132(R)-1, “Employers’ Disclosures about PostretirementASC 715-20-65-2, “Compensation — Retirement Benefits: Defined Benefit Plan Assets.Plans.FSP No. FAS 132(R)-1 amends SFAS No. 132 (revised 2003), “Employers’ Disclosures about Pensions and Other Postretirement Benefits,” to provideThis section provides guidance on an employer’s disclosures about plan assets of a defined benefit pension or other postretirement plan. This FSPsection will become effective for us on March 31, 2010. We do not currently anticipate that this FSPsection will have a material impact on our consolidated financial statements upon adoption.

8


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
     In June 2009, the FASB issued SFASStatement of Financial Accounting Standards (“SFAS”) No. 166, “Accounting for Transfers of Financial Assets.” SFAS No. 166 is a revision to SFAS No. 140, “Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities,” and amends the guidance on accounting for transfers of financial assets, including securitization transactions, where entities have continued exposure to risks related to transferred financial assets. SFAS No. 166 also expands the disclosure requirements for such transactions. SFAS No. 166 is currently not included in the Codification. This statementstandard will become effective for us on April 1, 2010. We are currently evaluating the impact of this standard on our consolidated financial statements.

8


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
     In June 2009, the FASB issued SFAS No. 167, “Amendments to FASB Interpretation No. 46(R).” SFAS No. 167 is a revision to FINFASB Interpretation No. 46(R), “Consolidation of Variable Interest Entities,” and amends the consolidation guidance for consolidation of VIEs under FIN No. 46(R).primarily related to the determination of the primary beneficiary of the VIE. This statement will become effective for us on April 1, 2010. SFAS No. 167 is currently not included in the Codification. We are currently evaluating the impact of this standard on our consolidated financial statements.
     In JuneAugust 2009, the FASB issued SFASASU No. 168, “The FASB Accounting Standards Codification and2009-05, “Measuring Liabilities at Fair Value.” ASU 2009-05 amends ASC 820, “Fair Value Measurements,” by providing additional guidance on determining the Hierarchyfair value of Generally Accepted Accounting Principles — A Replacement of FASB Statement No. 162.” The FASB Accounting Standards Codification (“Codification”) will become the source of authoritative GAAP recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the SEC under authority of federal securities laws are also sources of authoritative GAAPliabilities when a quoted price in an active market for SEC registrants. On the effective date, the Codification will supersede all then-existing non-SEC accounting and reporting standards.an identical liability is not available. This standardASU will become effective for us on JulyOctober 1, 2009. We2009 and is not expected to have a significant impact on the measurement of our liabilities as of that date; however, the ASU may affect the fair value measurement of liabilities for future acquisitions and divestitures.
     In September 2009, the FASB issued ASU No. 2009-12, “Fair Value Measurements and Disclosures (Topic 820): Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent),” which amends ASC 820-10, “Fair Value Measurements and Disclosures—Overall.” ASU No. 2009-12 permits a reporting entity to measure the fair value of certain alternative investments that do not expect that this standardhave a readily determinable fair value on the basis of the investments’ net asset value per share or its equivalent. This ASU also requires expanded disclosures. This guidance will become effective for us October 1, 2009 and will not have a material impact on our consolidated financial statements upon adoption; however, it may impact the valuation of our future investments.
     In October 2009, the FASB issued ASU No. 2009-13, “Revenue Recognition (Topic 605): Multiple-Deliverable Revenue Arrangements (a consensus of the FASB Emerging Issues Task Force),” which amends ASC 605-25, “Revenue Recognition: Multiple-Element Arrangements.” ASU No. 2009-13 addresses how to determine whether an arrangement involving multiple deliverables contains more than one unit of accounting and how to allocate consideration to each unit of accounting in the arrangement. This ASU replaces all references to fair value as the measurement criteria with the term selling price and establishes a hierarchy for determining the selling price of a deliverable. ASU No. 2009-13 also eliminates the use of the residual value method for determining the allocation of arrangement consideration. Additionally, ASU No. 2009-13 requires expanded disclosures. This ASU will become effective for us for revenue arrangements entered into or materially modified on or after April 1, 2011. Earlier application is permitted with required transition disclosures based on the period of adoption. We are currently evaluating the application date and the impact of this standard on our consolidated financial statements.
     In October 2009, the FASB issued ASU No. 2009-14, “Software (Topic 985): Certain Revenue Arrangements That Include Software Elements (a consensus of the FASB Emerging Issues Task Force).” ASU No. 2009-14 amends ASC 985-605, “Software: Revenue Recognition,” such that tangible products, containing both software and non-software components that function together to deliver the tangible product’s essential functionality, are no longer within the scope of ASC 985-605. It also amends the determination of how arrangement consideration should be allocated to deliverables in a multiple-deliverable revenue arrangement. This ASU will become effective for us for revenue arrangements entered into or materially modified on or after April 1, 2011. Earlier application is permitted with required transition disclosures based on the period of adoption. We are currently evaluating the application date and the impact of this standard on our consolidated financial statements. Both ASU No. 2009-13 and ASU No. 2009-14 must be adopted in the same period and must use the same transition disclosures.
2.  Business Acquisitions
     During the first quarter of 2009, we acquired McQueary Brothers Drug Company (“McQueary Brothers”) of Springfield, Missouri for approximately $190 million. McQueary Brothers is a regional distributor of pharmaceutical, health and beauty products to independent and regional chain pharmacies in the Midwestern U.S. This acquisition expanded our existing U.S. pharmaceutical distribution business. The acquisition was funded with cash on hand. Approximately $126 million of the purchase price allocation was assigned to goodwill, which primarily reflects the expected future benefits from synergies to be realized upon integrating the business. During the first quarter of 2010, the acquisition accounting was completed. Financial results for McQueary Brothers have been included within our Distribution Solutions segment since the date of acquisition.

9


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
     During the last two years, we also completed a number of other smaller acquisitions within both of our operating segments. Financial results for our business acquisitions have been included in our consolidated financial statements since their respective acquisition dates. Purchase prices for our business acquisitions have been allocated based on estimated fair values at the date of acquisition. Goodwill recognized for our business acquisitions is generally not expected to be deductible for tax purposes. Pro forma results of operations for our business acquisitions have not been presented because the effects were not material to the consolidated financial statements on either an individual or an aggregate basis.
3.  Gain on Sale of Equity Investment
     In July 2008, our Distribution Solutions segment sold its 42% equity interest in Verispan, L.L.C. (“Verispan”), a data analytics company, for a pre-tax gain of approximately $24 million or $14 million after income taxes. The pre-tax gain is included in other income, net on our condensed consolidated statements of operations.
4.  Share-Based PaymentPayments
     We provide share-based compensation for our employees, officers and non-employee directors, including stock options, an employee stock purchase plan, restricted stock (“RS”), restricted stock units (“RSUs”) and performance-based restricted stock units (“PeRSUs”) (collectively, “share-based awards”). Most of the Company’s share-based awards are granted in the first quarter of each fiscal year.
     Compensation expense for employee stock options is recognized on a straight-line basis over the requisite service period and is based on the grant-date fair value for the portion of the awards that is ultimately expected to vest. We have elected to expense the fair value of RS and RSUs with only graded vesting and service conditions on a straight-line basis over the requisite service period.

9


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
     PeRSUs are RSUs for which the number of RSUs awarded may be conditional upon the attainment of one or more performance objectives over a specified period. PeRSUs are accounted for as variable awards until the performance goals are reached and the grant date is established. The fair value of PeRSUs is determined by the product of the number of shares eligible to be awarded and expected to vest and the market price of the Company’s common stock, commencing at the inception of the requisite service period. During the performance period, the PeRSUs are re-valued using the market price and the performance modifier at the end of a reporting period. At the end of the performance period, if the goals are attained, the awards are granted and classified as RSUs and accounted for on that basis. For PeRSUs granted prior to 2009 with multiple vest dates, we recognize the fair value of these awards on a graded vesting basis over the requisite service period of two to four years. PeRSUs granted during or after 2009 and the related RSUs (granted during or after 2010) have a single vest date and accordingly, we recognize expense on a straight-line basis over the requisite service period of four years.
     Compensation expense is recognized for the portion of the awards that is ultimately expected to vest. We develop an estimate of the number of share-based awards whichthat will ultimately vest primarily based on historical experience. The estimated forfeiture rate established upon grant is re-assessed throughout the requisite service period. As required, the forfeiture estimates will be adjusted to reflect actual forfeitures when an award vests. The actual forfeitures in future reporting periods could be higher or lower than our current estimates.
     The compensation expense recognized under SFAS No. 123(R), “Share-Based Payment,” has been classified in the condensed consolidated statements of operations or capitalized on the condensed consolidated balance sheets in the same manner as cash compensation paid to our employees. There was no material share-based compensation expense capitalized as part of the cost of an asset for the quarters and six months ended JuneSeptember 30, 2009 and 2008.

10


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
     The components of share-based compensation expense and the related tax benefit for the quarters and six months ended JuneSeptember 30, 2009 and 2008 are shown in the following table:
                
         Quarter Ended Six Months Ended
 Quarter Ended June 30, September 30, September 30,
(In millions, except per share amounts) 2009 2008 2009 2008 2009 2008
RSUs and RS (1)
 $15 $19 
RSUs (1)
 $11 $15 $26 $34 
PeRSUs (2)
 2 2  11 5 13 7 
Stock options 4 4  5 4 9 8 
Employee stock purchase plan 3 3  2 1 5 4 
            
Share-based compensation expense 24 28  29 25 53 53 
Tax benefit for share-based compensation expense (3)
  (8)  (10)  (11)  (8)  (19)  (18)
            
Share-based compensation expense, net of tax $16 $18 
Share-base compensation expense, net of tax $18 $17 $34 $35 
            
Impact of share-based compensation:  
Earnings per share (4)
  
Diluted $0.06 $0.06  $0.07 $0.06 $0.13 $0.12 
Basic $0.06 $0.07  $0.07 $0.06 $0.13 $0.13 
(1)
(1) This expense was primarily the result of PeRSUs awarded in prior years, which converted to RSUs due to the attainment of goals during the applicable years’ performance period.
 
(2) Represents estimated compensation expense for PeRSUs that are conditional upon attaining performance objectives during the current year’s performance period.
 
(3) Income tax expense is computed based on applicable tax jurisdictions. Additionally, a portion of pre-tax compensation expense is not tax-deductible.
 
(4) Certain computations may reflect rounding adjustments.
     Share-based compensation expense is affected by our stock price, the number and typestype of annual share-based awards as well as assumptions regarding a number of complex and subjective variables and the related tax impact. These variables include, but are not limited to, the volatility of our stock price, employee stock option exercise behavior and the attainment of performance goals. As a result, the actual future share-based compensation expense may differ from historical amounts.

10


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
4.5.  Income Taxes
     The Company’s reported income tax raterates for the firstsecond quarters of 2010 and 2009 was 31.6%were 29.0% and 34.4%.13.7% and 30.3% and 23.7% for the first six months of 2010 and 2009. Fluctuations in our reported tax rate are primarily due to changes within state and foreign tax rates resulting from our business mix, including varying proportions of income attributable to foreign countries that have lower income tax rates. In addition,During the second quarter and first six months of 2010, income tax expense includesincluded net discrete items of a benefit of $1$13 million and an$14 million which primarily consisted of previously unrecognized tax benefits and international research and development tax credits. During the second quarter and first six months of 2009, income tax expense included net discrete items of $5a benefit of $76 million duringprimarily relating to previously unrecognized tax benefits and related accrued interest. The recognition of these discrete items was primarily due to the first quarterslapsing of 2010 and 2009.the statutes of limitations. Of the $76 million of net tax benefits, $65 million represented a non-cash benefit to McKesson. In accordance with ASC 740, “Income Taxes,” the net tax benefit was included in our income tax expense from continuing operations.

11


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
     As of JuneSeptember 30, 2009, we had $581$597 million of unrecognized tax benefits, of which $345$358 million would reduce income tax expense and the effective tax rate if recognized. During the next twelve months, it is reasonably possible that audit resolutions and the expiration of statutes of limitations could potentially reduce our unrecognized tax benefits by up to $27$19 million. However, this amount may change because we continue to have ongoing negotiations with various taxing authorities throughout the year. In Canada, we have received assessments from the Canada Revenue Agency for a total of $55 million related to transfer pricing for 2003, 2004 and 2005. We have appealed the assessment for 2003 and have filed a notice of objection for 2004. We plan to file a notice of objection for 2005.
     We continue to report interest and penalties on tax deficiencies as income tax expense. At JuneSeptember 30, 2009, before any tax benefits, our accrued interest on unrecognized tax benefits amounted to $106$109 million. We recognized $5$4 million and $9 million of interest expense before any tax benefits in our condensed consolidated statements of operations during the quarter and six months ended JuneSeptember 30, 2009. We have no material amounts accrued for penalties.
5.6. Earnings Per Share
     Basic earnings per share is computed by dividing net income by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share is computed similarsimilarly to basic earnings per share except that it reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock.
     The computations for basic and diluted earnings per share are as follows:
                
         Quarter Ended Six Months Ended
 Quarter Ended June 30, September 30, September 30,
(In millions, except per share data) 2009 2008 2009 2008 2009 2008
Net income $288 $235  $301 $327 $589 $562 
  
Weighted average common shares outstanding:  
Basic 270 277  267 275 268 276 
Effect of dilutive securities:  
Options to purchase common stock 1 4  3 4 2 4 
Restricted stock/Restricted stock units 1 1 
Restricted stock units 1 1 2 1 
            
Diluted 272 282  271 280 272 281 
            
  
Earnings per common share: (1)
 
Earnings Per Common Share: (1)
 
Diluted $1.06 $0.83  $1.11 $1.17 $2.17 $2.00 
Basic $1.07 $0.85  $1.13 $1.19 $2.19 $2.04 
(1) Certain computations may reflect rounding adjustments.
     Approximately 135 million and 129 million stock options were excluded from the computations of diluted net earnings per share for the quarters ended JuneSeptember 30, 2009 and 2008 as their exercise price was higher than the Company’s average stock price for the quarter. For the six months ended September 30, 2009 and 2008, the number of stock options excluded was approximately 10 million and 12 million.

1112


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
6.7. Goodwill and Intangible Assets, Net
     Changes in the carrying amount of goodwill for the quartersix months ended JuneSeptember 30, 2009 are as follows:
                        
 Distribution Technology   Distribution Technology  
(In millions) Solutions Solutions Total Solutions Solutions Total
Balance, March 31, 2009
 $1,869 $1,659 $3,528  $1,869 $1,659 $3,528 
Acquisition accounting adjustments  (3)   (3)
Goodwill acquired 3  3 
Acquisition accounting and other adjustments  (14)   (14)
Foreign currency translation adjustments 8 16 24  15 28 43 
            
Balance, June 30, 2009
 $1,874 $1,675 $3,549 
Balance, September 30, 2009
 $1,873 $1,687 $3,560 
     Information regarding intangible assets is as follows:
                
 June 30, March 31, September 30, March 31,
(In millions) 2009 2009 2009 2009
Customer lists $823 $824  $827 $824 
Technology 188 187  190 187 
Trademarks and other 71 70  71 70 
        
Gross intangibles 1,082 1,081  1,088 1,081 
Accumulated amortization  (452)  (420)  (483)  (420)
        
Intangible assets, net $630 $661  $605 $661 
     Amortization expense of intangible assets was $30$29 million and $59 million for the quartersquarter and six months ended JuneSeptember 30, 2009 and $34 million and $64 million for the quarter and six months ended September 30, 2008. The weighted average remaining amortization periods for customer lists, technology and trademarks and other intangible assets as of Juneat September 30, 2009 werewere: 7 years, 3 years and 6 years. Estimated annual amortization expense of these assets is as follows: $118$122 million, $111$112 million, $105$106 million, $86 million and $74 million for 2010 through 2014, and $166$164 million thereafter. All intangible assets were subject to amortization as of JuneSeptember 30, 2009 and March 31, 2009.
7.8.  Financing Activities
Accounts Receivable Sales Facility
     In May 2009, we renewed our accounts receivable sales facility for an additional one year period under terms similar to those previously in place. The renewed facility will expire in May 2010. The May 2009 renewal increased the committed balance from $1.0 billion to $1.1 billion, although from time-to-time the available amount may be less than $1.1 billion based on concentration limits and receivable eligibility requirements.

1213


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
     Through this facility, McKesson Corporation sells certain U.S. pharmaceutical trade accounts receivable on a non-recourse basis to a wholly-owned and consolidated subsidiary which then sells these receivables to a special purpose entity (“SPE”), which is a wholly-owned, bankruptcy-remote subsidiary of McKesson Corporation that is consolidated in our financial statements. This SPE then sells undivided interests in the receivables to third-party purchaser groups, each of which includes commercial paper conduits (“Conduits”), which are special purpose legal entities administered by financial institutions. Sales of undivided interests in the receivables by the SPE to the Conduits are accounted for as a sale in accordance with SFAS No. 140, “Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities,” because we have relinquished control of the receivables. Accordingly, accounts receivable sold under these transactions are excluded from receivables, net in the accompanying condensed consolidated balance sheets. Receivables sold and receivables retained by the Company are carried at face value, which due to the short-term nature of our accounts receivable and terms of the facility, approximates fair value. McKesson receives cash in the amount of the face value for the undivided interests in the receivables sold. No gain or loss is recorded upon sale as fee charges from the Conduits are based upon a floating yield rate and the period the undivided interests remain outstanding. Fee charges from the Conduits are accrued at the end of each month and are recorded within administrative expenses in the condensed consolidated statements of operations. Should we default under the accounts receivable sales facility, the Conduits are entitled to receive only collections on receivables owned by the SPE.
     We continue servicing the receivables sold. No servicing asset is recorded at the time of sale because we do not receive any servicing fees from third parties or other income related to servicing the receivables. We do not record any servicing liability at the time of sale as the receivables collection period is relatively short and the costs of servicing the receivables sold over the servicing period are insignificant. Servicing costs are recognized as incurred over the servicing period.
     Information regarding our outstanding balances related to our interests in accounts receivable sold or qualifying receivables retained is as follows:
                
 June 30, March 31, September 30, March 31,
(In millions) 2009 2009 2009 2009
Receivables sold outstanding(1)
 $ $  $ $ 
Receivables retained, net of allowance for doubtful accounts 4,752 4,814  4,833 4,814 
(1)
(1) Deducted from receivables, net in the condensed consolidated balance sheets.
     The following table summarizes the activity related to our interests in accounts receivable sold:
                
         Quarter Ended Six Months Ended
 Quarter Ended June 30, September 30, September 30,
(In millions) 2009 2008 2009 2008 2009 2008
Proceeds from accounts receivable sales $ $1,200  $  — $3,237 $  — $4,437 
Fees and charges(1)
 2 1  3 3 5 4 
(1)
(1) Recorded in operating expenses in the condensed consolidated statements of operations.
     The delinquency ratio for the qualifying receivables represented less than 1% of the total qualifying receivables as of JuneSeptember 30, 2009 and March 31, 2009.

1314


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
Revolving Credit Facility
     We have a syndicated $1.3 billion five-year, senior unsecured revolving credit facility which expires in June 2012. Borrowings under this credit facility bear interest based upon either a Prime rate or the London Interbank Offering Rate. Total borrowings under this facility were nil and $62$189 million for the first quarterssix months of 2010 and 2009. As of JuneSeptember 30, 2009 and March 31, 2009, there were no amounts outstanding under this facility.
Commercial Paper
     We issued and repaid commercial paper of nil and $496 million in commercial paperapproximately $3.3 billion for the first quarterssix months of 2010 and 2009. There were no commercial paper issuances outstanding at JuneSeptember 30, 2009 and March 31, 2009.
Long-Term Debt
     On February 12, 2009, we issued 6.50% notes due February 15, 2014 (the “2014 Notes”) in an aggregate principal amount of $350 million and 7.50% notes due February 15, 2019 (the “2019 Notes”) in an aggregate principal amount of $350 million. Interest is payable on February 15 and August 15 of each year beginning on August 15, 2009. The 2014 Notes will mature on February 15, 2014 and the 2019 Notes will mature on February 15, 2019. We utilized net proceeds, after offering expenses, of $693 million from the issuance of the 2014 Notes and 2019 Notes for general corporate purposes.
8.9.  Pension and Other Postretirement Benefit Plans
     Net periodic expense for the Company’s defined benefit pension and other postretirement benefit plans was $8$4 million and $3$12 million for the second quarter and first quarterssix months of 2010 compared to $2 million and 2009.$5 million for the comparable prior year periods. Cash contributions to these plans for the first quarterssix months of 2010 and 2009 were $10 million and $7$16 million.
     As previously reported in our 2009 Annual Report and Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2009 (“First Quarter 2010 Form 10-Q”), the McKesson Corporation Profit Sharing Investment Plan (“PSIP”) is a member of the settlement class in the Consolidated Securities Litigation Action. On April 27, 2009, the court issued an order approving the distribution of the settlement funds. TheOn October 9, 2009, the PSIP is anticipating receiving its share of the settlement ofreceived approximately $90 million during 2010. Approximately $30$119 million of the Consolidated Securities Litigation Action proceeds. Approximately $42 million of the proceeds are attributable to the allocated shares of McKesson common stock owned by the PSIP participants during the Consolidated Securities Litigation Action class holding period and will be allocated to the respective participants on that basis.basis as soon as administratively feasible during the third quarter of 2010. Approximately $60$77 million of the proceeds are attributable to the unallocated shares (the “Unallocated Proceeds”) of McKesson common stock owned by the PSIP in an employee stock ownership plan (the “ESOP”(“ESOP”) suspense account. In accordance with the plan terms, the PSIP will distribute all of the Unallocated Proceeds to current PSIP participants as soon as administratively feasible after the close of the plan year. The receipt of the Unallocated Proceeds by the PSIP is reimbursement for the loss in value of the Company’s common stock held by the PSIP in its ESOP suspense account during the Consolidated Securities Litigation Action class holding period and is not a contribution made by the Company to the PSIP or ESOP. Accordingly, there are no accounting consequences to the Company’s financial statements relating to the receipt of the Unallocated Proceeds by the PSIP.

1415


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
     The Company accounts for shares of its common stock contributed to the ESOP prior to 1993 in accordance with the American Institute of Certified Public Accountants Statement of Position (“SOP”) 76-3, “Accounting Practices for Certain Employee Stock Ownership Plans.” SOP 76-3 requires that compensation expense be recognized only to the extent that the Company contributes or commits to contribute to the ESOP. The Company accounts for all contributions of shares of its common stock made to the ESOP after 1993 under SOP 93-6, “Employers’ Accounting forASC 718-40, “Compensation — Stock Compensation: Employee Stock Ownership Plans.” During the first quarter of 2010, the Company contributed $1 million to the ESOP in order to extinguish the remaining ESOP loan and made no commitments to otherwise contribute to the PSIP or ESOP. Upon repayment, our ESOP became a non-leveraged ESOP. At JuneSeptember 30, 2009, of the 24 million shares of the Company’s common stock purchased by the ESOP since its inception, all but 66,444 shares have been allocated to PSIP participants. As a result of the payment in the first quarter of 2010, pre-tax PSIP expense for the first quartersix months of 2010 was $1 million. The Company anticipates that its PSIP expense for the full year will remain at $1 million, as it currently does not anticipate making or committing to make additional contributions to the PSIP or ESOP. As a result, our compensation expense in 2010 will be lower than 2009. During the first quartersix months of and full year 2009, PSIP expense was $17$28 million and $53 million.
     PSIP expense by segment for the quarters and six months ended JuneSeptember 30, 2009 and 2008 was as follows:
                
         Quarter Ended Six Months Ended
 Quarter Ended June 30, September 30, September 30,
(In millions) 2009 2008 2009 2008 2009 2008
Distribution Solutions $ $7  $  — $5 $  — $12 
Technology Solutions 1 9   6 1 15 
Corporate  1     1 
      
PSIP expense $1 $17  $ $11 $1 $28 
9.10. Financial Guarantees and Warranties
Financial Guarantees
     We have agreements with certain of our customers’ financial institutions under which we have guaranteed the repurchase of inventory (primarily for our Canadian business) at a discount in the event these customers are unable to meet certain obligations to those financial institutions. Among other requirements, these inventories must be in resalable condition. The inventory repurchase agreements mostly range from one to two years. Customer guarantees range from one to five years and were primarily provided to facilitate financing for certain customers. The majority of our other customer guarantees are secured by certain assets of the customer. We also have an agreement with one software customer that, under limited circumstances, may require us to secure standby financing. Because the amount of the standby financing is not explicitly stated, the overall amount of these guarantees cannot reasonably be estimated. As of JuneSeptember 30, 2009, the maximum amounts of inventory repurchase guarantees and other customer guarantees were $92$110 million and $11$12 million, none of which had been accrued.
     Our software license agreements generally include certain provisions for indemnifying customers against liabilities if our software products infringe a third party’s intellectual property rights. To date, we have not incurred any material costs as a result of such indemnification agreements and have not accrued any liabilities related to such obligations.

16


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
     In conjunction with certain transactions, primarily divestitures, we may provide routine indemnification agreements (such as retention of previously existing environmental, tax and employee liabilities) whose terms vary in duration and often are not explicitly defined. Where appropriate, obligations for such indemnifications are recorded as liabilities. Because the amounts of these indemnification obligations often are not explicitly stated, the overall maximum amount of these commitments cannot be reasonably estimated. Other than obligations recorded as liabilities at the time of divestiture, we have historically not made significant payments as a result of these indemnification provisions.

15


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
Warranties
     In the normal course of business, we provide certain warranties and indemnification protection for our products and services. For example, we provide warranties that the pharmaceutical and medical-surgical products we distribute are in compliance with the Food, Drug and Cosmetic Act and other applicable laws and regulations. We have received the same warranties from our suppliers, which customarily are the manufacturers of the products. In addition, we have indemnity obligations to our customers for these products, which have also been provided to us from our suppliers, either through express agreement or by operation of law.
     We also provide warranties regarding the performance of software and automation products we sell. Our liability under these warranties is to bring the product into compliance with previously agreed upon specifications. For software products, this may result in additional project costs, which are reflected in our estimates used for the percentage-of-completion method of accounting for software installation services within these contracts. In addition, most of our customers who purchase our software and automation products also purchase annual maintenance agreements. Revenues from these maintenance agreements are recognized on a straight-line basis over the contract period and the cost of servicing product warranties is charged to expense when claims become estimable. Accrued warranty costs were not material to the condensed consolidated balance sheets.
10.11. Financial Instruments
     At JuneSeptember 30, 2009 and March 31, 2009, the carrying amounts of cash and cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments. All highly liquid debt instruments purchased with a maturity of three months or less at the date of acquisition are included in cash and cash equivalents. Included in cash and cash equivalents at JuneSeptember 30, 2009 and March 31, 2009 are money market fund investments of $2.0$1.8 billion and $1.7 billion which are reported at fair value. The fair value of these investments was determined by using quoted prices for identical investments in active markets which are considered to be Level 1 inputs under SFAS No. 157,ASC 820, “Fair Value Measurements.Measurements and Disclosures.
     The carrying amounts and estimated fair values of our long-term debt and other financing were $2,509$2,511 million and $2,657$2,749 million at JuneSeptember 30, 2009 and $2,509 million and $2,545 million at March 31, 2009. The estimated fair value of our long-term debt and other financing was determined using quoted market prices and other inputs that were derived from available market information and may not be representative of actual values that could have been or will be realized in the future.

17


11.McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
12. Other Commitments and Contingent Liabilities
     In addition to commitments and obligations in the ordinary course of business, we are subject to various claims, other pending and potential legal actions for damages, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of our business. In accordance with SFAS No. 5, “Accounting for Contingencies,ASC 450, “Contingencies,” we record a provision for a liability when management believes that it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. We believe we have adequate provisions for any such matters. Management reviews these provisions at least quarterly and adjusts these provisions to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular case.case and during the second quarter of 2010, we reversed a previously established litigation reserve of $20 million. Because litigation outcomes are inherently unpredictable, these decisions often involve a series of complex assessments by management about future events that can rely heavily on estimates and assumptions and it is possible that the ultimate cost of these matters could impact our earnings, either negatively or positively, in the quarter of their resolution.

16


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
     Based on our experience, we believe that any damage amounts claimed in the specific matters referenced in our 2009 Annual Report, First Quarter 2010 Form 10-Q and those matters discussed below are not meaningful indicators of our potential liability. We believe that we have valid defenses to these legal proceedings and are defending the matters vigorously. Nevertheless, the outcome of any litigation is inherently uncertain. We are currently unable to estimate the remaining possible losses in these unresolved legal proceedings. Should any one or a combination of more than one of these proceedings against us be successful, or should we determine to settle any or a combination of these matters on unfavorable terms, we may be required to pay substantial sums, become subject to the entry of an injunction, or be forced to change the manner in which we operate our business, which could have a material adverse impact on our financial position or results of operations.
     As more fully described in our previous public reports filed with the SEC, we are involved in numerous legal proceedings. For a discussion of these proceedings, please refer to the Financial Note 18,entitled “Other Commitments and Contingent Liabilities,”Liabilities” included in our 2009 Annual Report.Report and our First Quarter 2010 Form 10-Q. Significant developments in previously reported proceedings and in other litigation and claims since the referenced filings are set out below.
     As previously reported, in January ofon July 14, 2009, the Georgia Court of Appeals acceptedissued its opinion on our appeals from trial court rulings denying our summary judgment and expert disqualification motions in the last two remaining lawsuits filed against the Company arising out of our January 12, 1999 acquisition of HBO & Company,Holcombe T. Green and HTG Corp. v. McKesson Corporation, et al.(Georgia State Court, Fulton County, Case No. 06-VS-096767-D) andHall Family Investments, L.P. v. McKesson Corporation, et al.(Georgia State Court, Fulton County, Case No. 06-VS-096763-F). On July 14, 2009, the Georgia Court of Appeals issued its opinion on our appeals,, ruling that the trial court committed error in denying our motionmotions for summary judgment and reversing the trial court’s ruling.in those two matters. On July 23, 2009, the plaintiffs petitioned the Georgia Supreme Court to take antheir appeal from the decision of the Georgia Court of Appeals. The Company will oppose the plaintiffs petition toAppeals decision. On October 19, 2009, the Georgia Supreme Court.Court issued orders rejecting plaintiffs’ petition.

18


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
     We have previously reported on certain private party class action litigation filed against the Company in the United States District Court for Massachusetts relating to alleged misstatements and manipulations of the benchmark for drug reimbursement known as Average Wholesale Price (“AWP”) and regardingrelating to a proposed settlement of that litigation,New England Carpenters Health Benefits Fund, et al. v. First DataBank, Inc. and McKesson Corporation,(Civil Action No. 1:05-CV-11148-PBS) (the “Private Payor RICO Action”) andNew England Carpenters Health Benefits Fund, et al. v. McKesson Corporation,(Civil Action No. 1:07-CV-12277-PBS) (the “Antitrust Action”). The final approval hearing on the Company’s previously disclosed settlement of private party claims was conducted by the trial court as scheduled on July 23, 2009 and on July 24, 2009, the trial court issued an order approving the settlement. On August 21, 2009, a motion by a settlement class member challenging the settlement approval order was filed. Prior to any ruling on that motion, a final judgment based on the settlement and dismissing all of the private party claims was entered by the trial court on August 31, 2009. On October 9, 2009, in accordance with the terms of the settlement, we paid $295 million into the settlement escrow account as the final installment on the $350 million total settlement and we recorded the additional payment of $295 million as restricted cash. Between September 29 and 30, 2009, four notices of appeal were filed by settlement class members challenging the final judgment approving the class settlement. The appeals relate to the award of attorneys’ fees and costs, the settlement’s covenant not to sue provision and the mechanisms for identifying absent settlement class members. On October 13, 2009, appellee-plaintiffs filed a motion with the First Circuit Court of Appeals to consolidate the appeals. No briefing schedule has yet been set.
     As previously reported regardingRegarding the consolidated public payor actions, collectively known asIn re McKesson Governmental Entities Average Wholesale Price Litigation,pending in United States District Court for the District of Massachusetts, which actions are based on allegations nearly identical to those made in the AWPPrivate Payor RICO Actionand theAntitrust Actionreferenced above (Board of County Commissioners of Douglas County, Kansas v. McKesson Corporation, et al., (Civil Action No. 1:08-CV-11349-PBS) (“Douglas County, Kansas Action”),San Francisco Health Plan, et al. v. McKesson Corporation, (Civil Action No. 1:08-CV-10843-PBS) (“San Francisco Action”),State of Connecticut v. McKesson Corporation, (Civil Action No. 1:08-CV-10900-PBS) (“Connecticut Action”)), the trial court set a discovery cut-off of October 30, 2009, a class certification hearing in theDouglas County, KansasandSan Francisco Actionsof February 10, 2010 and trial in theConnecticut Actionfor July 19, 2010. No trial date has yet been set or proposed in theSan FranciscoandDouglas County, Kansas Actions. On July 10, 2009, plaintiffs in theSan Francisco, ConnecticutandDouglas County, Kansas Actionsfiled an unopposed motion to modify the court’s scheduling order by movingextended the discovery cut-off in all of the consolidated actions to January 14,8, 2010, reset the class certification hearing in theDouglas County, KansasandSan Francisco Actionstofor April 28, 2010 and left unchanged the trial in theConnecticut Action,to Octoberpreviously set for July 19, 2010. The courtNo trial date has not yet ruled on plaintiffs’been proposed or set in theSan FranciscoandDouglas County, Kansas Actions.Our previously disclosed motion to modifystay the previously described schedule. The parties to theIn re McKesson Governmental Entities Average Wholesale Price Litigationare currently engaged in class and merits discovery.

17


McKESSON CORPORATION
FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
     Also in connection with the previously disclosed public payor AWP matters, on May 20, 2009, an action, was filed in the United States District Court for the District of Massachusetts by Oakland County, Michigan and the City of Sterling Heights, Michigan against the Company as the sole defendant, alleging violations of the Racketeer Influenced and Corrupt Organizations Act (“RICO”), the Michigan Antitrust Reform Act, the Michigan Consumer Protection Act, the California Cartwright Act and common law fraud and seeking damages, treble damages, interest and attorneys’ fees, all in unspecified amounts,Oakland County, Michigan et al. v. McKesson Corporation, (Civil Action No. 1:09-CV-10843-PBS) (“Michigan Action”). On July 15, 2009, the Company filed a motion to stay theMichigan Actionpending the court’s class certification determination in theDouglas County, Kansas Action.
     As previously reported, was granted on November 21, 2008 the Company announced that it had reached an agreement with plaintiffs to pay $350 million in settlement of all claims alleged in thePrivate Payor RICO Actionalong with the claims brought in theAntitrust Action. The Company also announced on November 21 that it recorded a reserve of $143 million for pending and expected claims by public entities. The settlement provides that the Company will pay $350 million into a settlement escrow in installments following preliminary and final approval by the U.S. District Court. To date, approximately $55 million has been paid by the Company into the settlement escrow, and the balance of the $350 million is expected to be paid into the settlement escrow during the second quarter of 2010. Accordingly, $350 million is recorded in current liabilities on our condensed consolidated balance sheets at June 30,August 4, 2009.
     On July 7,September 2, 2009, in the previously reporteddisclosed matter,qui tamRoby v. McKesson HBOC, Inc. et al.false claims lawsuit brought, (Superior Court for Yolo County, California, Case No. CV01-573), the California Supreme Court conducted a hearing on petitioner Roby’s appeal from the previously described rulings by Relator Thomas F. Jamison,the California Court of Appeals. The appeal has been submitted and the United States by way of its complaintparties are awaiting a ruling from the California Supreme Court.
     On September 24, 2009, in intervention,the previously described antitrust action,RxUSA v. Alcon Laboratories et al.,(Case No. 06-CV-3447-DRH) brought against the Company, McKesson Medical-Surgical MediMart Inc.two of its employees and others, allother drug wholesaler and manufacturer defendants, filedthe trial court issued its order granting “with prejudice” defendants’ motions to dismiss and on September 28, 2009, the Relator astrial court entered judgment dismissing all of plaintiff’s claims. On October 23, 2009, plaintiff filed a plaintiff based onNotice of Appeal from the trial court’s lackorder of subject matter jurisdiction,United States v. McKesson Corporation, et al., (Civil Action No. 2:08-CV-00214-SA,) pendingdismissal and judgment in the United States District Court of Appeals for the Northern District of Mississippi. Defendants’ motions to dismiss are based on their contention that the Relator was not the original source of the claims which he attempts to pursue in hisqui tamaction. The Relator has not yet filed his opposition to these motions and no date has been set for a hearing on them. Also, the trial court has not yet scheduled a hearing date for defendants’ previously described motions to dismiss the United States’ complaint in intervention on grounds that the complaint fails to make allegations with required particularity and that it fails to state a legal claim.Second Circuit.

19


McKESSON CORPORATION
12.FINANCIAL NOTES (CONTINUED)
(UNAUDITED)
13. Stockholders’ Equity
     Comprehensive income is as follows:
                
         Quarter Ended Six Months Ended
 Quarter Ended June 30, September 30, September 30,
(In millions) 2009 2008 2009 2008 2009 2008
Net income $288 $235  $301 $327 $589 $562 
Foreign currency translation adjustments and other 95 10  87  (59) 182  (49)
      
Comprehensive income $383 $245  $388 $268 $771 $513 
     In April 2008, the Company’s Board of Directors (the “Board”) approved a plan to repurchase $1.0 billion of the Company’s common stock, of which $830 million remained available at March 31, 2009. During the second quarter and first quartersix months of 2010, we repurchased 71 million and 8 million shares for $275$24 million and $299 million, leaving $555$531 million available for future repurchases as of JuneSeptember 30, 2009. Stock repurchases may be made from time-to-time in open market or private transactions.
     In July 2008, the Board authorized the retirement of shares of the Company’s common stock that may be repurchased from time-to-time pursuant to its stock repurchase program. During the second quarter of 2009, all of the 4 million repurchased shares, which we purchased for $204 million, were formally retired by the Company. The retired shares constitute authorized but unissued shares. We elected to allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings. As such, $165 million was recorded as a decrease to retained earnings.

1820


McKESSON CORPORATION
FINANCIAL NOTES (CONCLUDED)
(UNAUDITED)
13.14.  Segment Information
       We report our operations in two operating segments: McKesson Distribution Solutions and McKesson Technology Solutions. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. We evaluate the performance of our operating segments based on operating profit before interest expense, income taxes and results from discontinued operations. Financial information relating to our reportable operating segments and reconciliations to the condensed consolidated totals is as follows:
                
         Quarter Ended Six Months Ended
 Quarter Ended June 30, September 30, September 30,
(In millions) 2009 2008 2009 2008 2009 2008
Revenues
  
Distribution Solutions(1)
  
Direct distribution & services $17,038 $16,428  $17,850 $16,611 $34,888 $33,039 
Sales to customers’ warehouses 6,051 6,664  5,501 6,319 11,552 12,983 
      
Total U.S. pharmaceutical distribution & services 23,089 23,092  23,351 22,930 46,440 46,022 
Canada pharmaceutical distribution & services 2,140 2,241  2,255 2,182 4,395 4,423 
Medical-Surgical distribution & services 685 627 
Medical-Surgical distribution and services 734 700 1,419 1,327 
      
Total Distribution Solutions 25,914 25,960  26,340 25,812 52,254 51,772 
      
Technology Solutions  
Services 589 564  613 582 1,202 1,146 
Software and software systems 130 138  142 140 272 278 
Hardware 24 42  35 40 59 82 
      
Total Technology Solutions 743 744  790 762 1,533 1,506 
      
Total $26,657 $26,704  $27,130 $26,574 $53,787 $53,278 
      
Operating profit(2)
  
Distribution Solutions $430 $384 
Distribution Solutions(3)
 $415 $406 $845 $790 
Technology Solutions 103 66  116 71 219 137 
      
Total 533 450  531 477 1,064 927 
Corporate  (64)  (58)  (80)  (63)  (144)  (121)
Litigation Credit(4)
 20  20  
Interest Expense  (48)  (34)  (47)  (35)  (95)  (69)
      
Income Before Income Taxes $421 $358  $424 $379 $845 $737 
(1) Revenues derived from services represent less than 1% of this segment’s total revenues for the first quarters of 2010 and 2009.six months ended September 30, 2009 and 2008.
 
(2) Operating profit includes net earnings of nil and $5 million and $8 million of net earnings from equity investments for the second quarter and first quarterssix months of 2010 and 2009,net losses of $3 million and net earnings of $5 million for the comparable prior year periods which were primarily recorded within our Distribution Solutions segment.
(3)Results for 2009 include a $24 million pre-tax gain on the sale of our 42% equity interest in Verispan.
(4)Operating profit for 2010 includes a litigation credit of $20 million.
15.  Subsequent Event
       In October 2009, our Distribution Solutions segment sold its 50% equity interest in McKesson Logistics Solutions L.L.C. (“MLS”), a logistics company, for a pre-tax gain of approximately $17 million or $14 million after income taxes. The pre-tax gain will be included in other income, net on our condensed consolidated statements of operations in the third quarter of 2010.

1921


McKESSON CORPORATION
FINANCIAL REVIEW
(UNAUDITED)
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Financial Overview
                        
             Quarter Ended Six Months Ended
 Quarter Ended June 30, September 30, September 30,
(In millions, except per share data) 2009 2008 Change 2009 2008 Change 2009 2008 Change
Revenues $26,657 $26,704  % $27,130 $26,574  2% $53,787 $53,278  1%
Income Before Income Taxes $421 $358 18  $424 $379 12 $845 $737 15 
Income Tax Expense $(123) $(52) 137 $(256) $(175) 46 
Net Income $288 $235 23  $301 $327  (8) $589 $562 5 
Diluted Earnings Per Share $1.06 $0.83 28 
Diluted Earnings Per Share: $1.11 $1.17  (5) $2.17 $2.00 9 
Weighted Average Diluted Shares 272 282  (4) 271 280  (3) 272 281  (3)
     Revenues for the firstsecond quarter of 2010 grew 2% to $27.1 billion and for the first six months of $26.72010 revenues grew 1% to $53.8 billion approximatedcompared to the same periodperiods a year ago primarily due to increases associated with market growth rates being fully offset by lost business. Netbusiness in late 2009.
     Income before income taxes for the second quarter of 2010 grew 12% to $424 million and for the first quarter of 2010 increased by 23% from $235 millionsix months grew 15% to $288 million compared to the same period a year ago and diluted earnings per share increased 28% from $0.83 to $1.06. Financial results$845 million. Results for 2010 were positively impacted by an increase in our Distribution Solutions and Technology Solutions segments’ operating profit, partially offset by a $24 million pre-tax gain on the sale of our 42% equity interest in Verispan, L.L.C. (“Verispan”) in 2009.
     Net income for the second quarter of 2010 decreased 8% to $301 million and for the first six months increased 5% to $589 million. For those same periods, diluted earnings per share decreased 5% to $1.11 and increased 9% to $2.17 compared to the prior year. The decreases in the second quarter of 2010 primarily reflect the recognition in the second quarter of 2009 of $76 million of previously unrecognized tax benefits and related interest as a result of the effective settlement of uncertain tax positions. Financial results for the first six months of 2010 were positively impacted by an increase in our Distribution Solutions and Technology Solution segments’ operating profit. Diluted earnings per share also benefited from a decrease in our weighted average shares outstanding due to our share repurchases.

22


McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)
Results of Operations
     Revenues:
                        
             Quarter Ended Six Months Ended
 Quarter Ended June 30, September 30, September 30,
(In millions) 2009 2008 Change 2009 2008 Change 2009 2008 Change
Distribution Solutions  
Direct distribution & services $17,038 $16,428  4% $17,850 $16,611  7% $34,888 $33,039  6%
Sales to customers’ warehouses 6,051 6,664  (9) 5,501 6,319  (13) 11,552 12,983  (11)
               
Total U.S. pharmaceutical distribution & services 23,089 23,092   23,351 22,930 2 46,440 46,022 1 
Canada pharmaceutical distribution & services 2,140 2,241  (5) 2,255 2,182 3 4,395 4,423  (1)
Medical-Surgical distribution & services 685 627 9  734 700 5 1,419 1,327 7 
               
Total Distribution Solutions 25,914 25,960   26,340 25,812 2 52,254 51,772 1 
       
 
Technology Solutions  
Services 589 564 4  613 582 5 1,202 1,146 5 
Software and software systems 130 138  (6) 142 140 1 272 278  (2)
Hardware 24 42  (43) 35 40  (13) 59 82  (28)
               
Total Technology Solutions 743 744   790 762 4 1,533 1,506 2 
               
Total Revenues $26,657 $26,704   $27,130 $26,574 2 $53,787 $53,278 1 
     Revenues for the firstsecond quarter of 2010 approximatedincreased 2% and for the first six months of 2010 increased 1% compared to the same periodperiods a year ago. Ourago primarily driven by continued growth in our Distribution Solutions segment, which accounted for approximatelyover 97% of our consolidated revenues.

20


McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)
     U.S. pharmaceutical directDirect distribution and services revenues increased primarily reflecting market growth rates (which include growing drug utilization and price increases, offset in part by the increased use of lower priced generics), a shift of revenues from sales to customers’ warehouses to direct store delivery and expanded business with newmarket growth rates (which include price increases and existing customers.growing drug utilization). This increase was partially offset by the loss of several customers. U.S. pharmaceutical salescustomers in late 2009. Sales to customers’ warehouses decreased primarily as a result of a shift of revenues to direct store delivery and for the first six months of 2010 were also impacted by the loss of a large customer.
     Canadian pharmaceutical distribution and services revenues decreased primarily reflectingincreased on a 15%constant currency basis by 9% and 10% in the second quarter and first six months of 2010 due to market growth rates. The growth was offset by an unfavorable foreign exchange rate impact partially offset by market growth ratesof 6% and new11% in the second quarter and expanded business. On a constant currency basis, revenues grew 10%.the first six months of 2010.
     Medical-Surgical distribution and services revenues increased primarily reflecting business acquisitions and additionally, for the first six months of 2010, new business, market growth rates. These revenues were also aided byrates and an increase in demand stemming from the H1N1 virus.flu season.
     Technology Solutions revenues approximated thatincreased in the second quarter and first six months of 2010 compared to the same periodperiods a year ago. IncreasedMcKesson’s Horizon Enterprise Revenue ManagementTM solution became generally available in the second quarter of 2010 and as a result we recognized previously deferred revenue. Revenues also increased due to higher services revenues primarily reflecting greaterincreases in claims processing and maintenance revenuesmaintenance. These increases were fullypartially offset by lower hardware installations and unfavorable foreign exchange rates.

23


McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)
     Gross Profit:
                        
             Quarter Ended Six Months Ended
 Quarter Ended June 30, September 30, September 30,
(Dollars in millions) 2009 2008 Change 2009 2008 Change 2009 2008 Change
Gross Profit  
Distribution Solutions $954 $934  2% $960 $951  1% $1,914 $1,885  2%
Technology Solutions 349 334 4  375 351 7 724 685 6 
               
Total $1,303 $1,268 3  $1,335 $1,302 3 $2,638 $2,570 3 
               
 
Gross Profit Margin  
Distribution Solutions  3.68%  3.60% 8 bp  3.64%  3.68% (4)bp  3.66%  3.64% 2bp
Technology Solutions 46.97 44.89 208  47.47 46.06 141 47.23 45.48 175 
Total 4.89 4.75 14  4.92 4.90 2 4.90 4.82 8 
     Gross profit increased 3% in the second quarter and first quartersix months of 2010 compared to the same periodperiods a year ago. As a percentage of revenues, gross profit margin increased in boththe second quarter and first six months of our segments2010 compared to the same periodperiods a year ago.
     DuringDistribution Solutions segment’s gross profit margin decreased in the firstsecond quarter of 2010 due to a decline in sell margin, partially offset by a benefit from increased margins from sales of generic drugs and higher buy side margin. The buy side increase primarily reflects compensation from branded pharmaceutical manufacturers. In the first six months of 2010, Distribution Solutions segment’s gross profit margin for our Distribution Solutions segment was positively impacted by higher buy sideincreased margins (primarily reflecting the volume and timing of compensation from branded pharmaceuticals), the benefit of increased sales of generic drugs withand higher margins and a benefit associated with a lower proportion of revenues within the segment attributed to sales to customers’ warehouses,buy side margin, which generally have lower gross profit margins relative to other revenues within the segment. These increases werewas partially offset by a decline in sell margin.
     Technology Solutions segment’s gross profit margin increased primarily due to McKesson’s Horizon Enterprise Revenue ManagementTM solution becoming generally available in the second quarter of 2010. As a result, we recognized previously deferred revenue for which some associated expenses were recognized as incurred in prior periods. Gross profit margin also improved due to a change in product mix.revenue mix and cost containment efforts.
Operating Expenses and Other Income:
                         
  Quarter Ended Six Months Ended
  September 30, September 30,
(Dollars in millions) 2009 2008 Change 2009 2008 Change
 
Operating Expenses                        
Distribution Solutions $546  $570   (4)% $1,077  $1,132   (5)%
Technology Solutions  260   282   (8)  507   552   (8)
Corporate  82   69   19   148   134   10 
Litigation credit  (20)    NM   (20)    NM 
                 
Total $868  $921   (6) $1,712  $1,818   (6)
                 
Operating Expenses as a Percentage of Revenues                        
Distribution Solutions  2.07%  2.21% (14)bp  2.06%  2.19% (13)bp
Technology Solutions  32.91   37.01   (410)  33.07   36.65   (358)
Total  3.20   3.47   (27)  3.18   3.41   (23)
                         
Other Income, Net                        
Distribution Solutions (1)
 $1  $25   (96)% $8  $37   (78)%
Technology Solutions  1   2   (50)  2   4   (50)
Corporate  2   6   (67)  4   13   (69)
                 
Total $4  $33   (88) $14  $54   (74)
(1)Includes Distribution Solutions segment’s sale of its 42% equity interest in Verispan during the second quarter of 2009.

2124


McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)
     Operating Expenses and Other Income:
             
  Quarter Ended June 30,
(Dollars in millions) 2009 2008 Change
 
Operating Expenses            
Distribution Solutions $531  $562   (6)%
Technology Solutions  247   270   (9)
Corporate  66   65   2 
     
Total $844  $897   (6)
     
Operating Expenses as a Percentage of Revenues            
Distribution Solutions  2.05%  2.16%  (11) bp
Technology Solutions  33.24   36.29   (305)
Total  3.17   3.36   (19)
             
Other Income, Net            
Distribution Solutions $7  $12   (42)%
Technology Solutions  1   2   (50)
Corporate  2   7   (71)
     
Total $10  $21   (52)
 
Operating expenses decreased 6% for the second quarter and the first six months of 2010 compared to the same periodperiods a year ago. As a percentage of revenues, operating expenses decreased 27 basis points (“bp”) and 23 bp for these same periods. Operating expenses in 2010 benefited from a decrease in employee compensation costs, which includes various cost containment efforts as well as lower profit sharing investment plan expenses as more fully described below, and other cost containment efforts.below. Additionally, operating expenses in 2010 decreased as a result of foreign exchange rates andother cost containment efforts, the salesales of two businesses during the first and third quarters in 2009 and favorable foreign exchange rates. Operating expenses also benefited from the reversal of 2009.a previously established litigation reserve as further discussed in Financial Note 12, “Other Commitments and Contingent Liabilities.” Decreases in operating expenses were partially offset by an increase in expenses associated with our 2009 business acquisitions. As a percentage of revenues, operating expenses decreased 19 basis points (“bp”) compared to the same period a year ago primarily reflecting the decrease in employee compensation expenses, other cost containment efforts and the sale of the two businesses.
     As previously reported in our Annual Report on Form 10-K for the fiscal year ended March 31, 2009 and Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2009, the McKesson Corporation Profit Sharing Investment Plan (“PSIP”) is a member of the settlement class in the Consolidated Securities Litigation Action. On April 27, 2009, the court issued an order approving the distribution of the settlement funds. TheOn October 9, 2009, the PSIP is anticipating receiving its share of the settlement ofreceived approximately $90 million during 2010. Approximately $30$119 million of the Consolidated Securities Litigation Action proceeds. Approximately $42 million of the proceeds are attributable to the allocated shares of McKesson common stock owned by the PSIP participants during the Consolidated Securities Litigation Action class holding period and will be allocated to the respective participants on that basis.basis as soon as administratively feasible during the third quarter of 2010. Approximately $60$77 million of the proceeds are attributable to the unallocated shares (the “Unallocated Proceeds”) of McKesson common stock owned by the PSIP in an employee stock ownership plan (the “ESOP”(“ESOP”) suspense account. In accordance with the plan terms, the PSIP will distribute all of the Unallocated Proceeds to current PSIP participants as soon as administratively feasible after the close of the plan year. The receipt of the Unallocated Proceeds by the PSIP is reimbursement for the loss in value of the Company’s common stock held by the PSIP in its ESOP suspense account during the Consolidated Securities Litigation Action class holding period and is not a contribution made by the Company to the PSIP or ESOP. Accordingly, there are no accounting consequences to the Company’s financial statements relating to the receipt of the Unallocated Proceeds by the PSIP.
     The Company anticipates that its PSIP expense for the full year will be negligible, as it currently does not anticipate making or committing to make additional contributions to the PSIP or ESOP. As a result, our compensation expense in 2010 will be lower than 2009. During the first quartersix months of and full year 2009, PSIP expense was $17$28 million and $53 million.

22


McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)
     PSIP expense by segment for the quarters and six months ended JuneSeptember 30, 2009 and 2008 was as follows:
                
         Quarter Ended Six Months Ended
 Quarter Ended June 30, September 30, September 30,
(In millions) 2009 2008 2009 2008 2009 2008
Distribution Solutions $ $7  $ $5 $ $12 
Technology Solutions 1 9   6 1 15 
Corporate  1     1 
      
PSIP expense $1 $17  $ $11 $1 $28 
     Distribution Solutions segment’s operating expenses decreased compared to the same periodperiods a year ago primarily reflecting the sale of two businesses during the first and third quarters of 2009, lower employee compensationour continued focus on containing costs, no PSIP expense in 2010 and the favorable impact of foreign exchange rates. These decreases were partially offset by an increase in expenses associated with our 2009 business acquisitions. Operating expenses as a percentage of revenues decreased compared with the same periodperiods a year ago primarily due to the sale of two businesses during the first and third quarters of 2009, our continued focus on containing costs and due to lower employee compensation costs.no PSIP expense in 2010.
     Technology Solutions segment’s operating expenses decreased during the first quarter of 2010 compared to the same periodperiods a year ago mostly due to cost containment efforts, lower PSIP expense and lower employee compensation costs.the favorable impact of foreign exchange rates. During the third and fourth quarters of 2009, the segment implemented reduction in workforce plans which benefited the second quarter and first quartersix months of 2010.
     Corporate expenses during the first quarter of 2010 approximated that of the same period a year ago as additional costs incurred to support various initiatives were offset by lower employee compensation costs.
     Other income, net decreased in the first quarter of 2010 compared to the same period a year ago primarily reflecting a decrease in interest income due to lower interest rates and a decrease in income from our equity investments.
Segment Operating Profit and Corporate Expenses:
             
  Quarter Ended June 30,
(Dollars in millions) 2009 2008 Change
 
Segment Operating Profit(1)
            
Distribution Solutions $430  $384   12%
Technology Solutions  103   66   56 
       
Subtotal  533   450   18 
Corporate Expenses, Net  (64)  (58)  10 
Interest Expense  (48)  (34)  41 
       
Income Before Income Taxes $421  $358   18 
       
             
Segment Operating Profit Margin            
Distribution Solutions  1.66%  1.48%  18 bp
Technology Solutions  13.86   8.87   499 
 
(1) Segment operating profit includes gross profit, net of operating expenses plus other income for our two business segments.

2325


McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)
     Corporate expenses increased compared to the same periods a year ago mostly due to additional costs incurred to support various initiatives. The increase during the second quarter is primarily due to higher compensation, pension and benefit costs. In the second quarter of 2010, we reversed a previously established litigation reserve. See Financial Note 12, “Other Commitments and Contingent Liabilities,” for further information.
     Other income, net decreased primarily reflecting a $24 million pre-tax gain from the sale of our 42% equity interest in Verispan recorded in 2009 and a decrease in interest income due to lower interest rates in 2010. Interest income is primarily recorded within our Corporate segment and financial results for Verispan were recorded within our Distribution Solutions segment.
Segment Operating Profit and Corporate Expenses:
                         
  Quarter Ended Six Months Ended
  September 30, September 30,
(Dollars in millions) 2009 2008 Change 2009 2008 Change
 
Segment Operating Profit(1)
                        
Distribution Solutions $415  $406   2% $845  $790   7%
Technology Solutions  116   71   63   219   137   60 
                 
Subtotal  531   477   11   1,064   927   15 
Corporate Expenses, Net  (80)  (63)  27   (144)  (121)  19 
Interest Expense  (47)  (35)  34   (95)  (69)  38 
Litigation Credit  20     NM   20     NM 
                 
Income Before Income Taxes $424  $379   12  $845  $737   15 
                 
Segment Operating Profit                        
Margin                        
Distribution Solutions  1.58%  1.57% 1bp  1.62%  1.53% 9bp
Technology Solutions  14.68   9.32   536   14.29   9.10   519 
(1)Segment operating profit includes gross profit, net of operating expenses plus other income for our two business segments.
Operating profit as a percentage of revenues in our Distribution Solutions segment increased for the second quarter and the first six months of 2010 compared to the same periods a year ago primarily reflecting lower operating expenses as a percentage of revenues, partially offset by the gain on the sale of our equity interest in Verispan during the second quarter of 2009. In addition, operating profit as a percentage of revenues was negatively impacted by a lower gross profit margin for the second quarter of 2010.
     Operating profit as a percentage of revenues in our Technology Solutions segmentssegment increased compared to the same periodperiods a year ago primarily reflecting a declinedecreases in operating expenses as a percentage of revenues and an increase in gross profit margin.
     Corporate expenses, net of other income, increased primarily due to additional operating expenses as previously discussed and a decrease in interest income.
     Interest Expense:Interest expense for the first quarter of 2010 increased compared to the same periodperiods a year ago primarily due to our issuance of $700 million of long-term notes in February 2009.

26


McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)
     Income Taxes:The Company’s reported income tax raterates for the firstsecond quarters of 2010 and 2009 was 31.6%were 29.0% and 34.4%.13.7% and 30.3% and 23.7% for the first six months of 2010 and 2009. Fluctuations in our reported tax rate are primarily due to changes within state and foreign tax rates resulting from our business mix, including varying proportions of income attributable to foreign countries that have lower income tax rates. In addition,During the second quarter of 2010, income tax expense includesincluded $13 million of net income tax benefits for discrete items primarily relating to previously unrecognized tax benefits, related accrued interest and international tax credits. During the second quarter and first six months of 2009, income tax expense included net discrete items of a benefit of $1$76 million primarily relating to previously unrecognized tax benefits and an expenserelated accrued interest. The recognition of $5these discrete items was primarily due to the lapsing of the statutes of limitations. Of the $76 million during the first quarters of 2010 and 2009.net tax benefits, $65 million represented a non-cash benefit to McKesson.
     Net Income:Net income was $288$301 million and $235$327 million for the firstsecond quarters of 2010 and 2009, or $1.06$1.11 and $0.83$1.17 per diluted share. Net income was $589 million and $562 million for the first six months of 2010 and 2009, or $2.17 and $2.00 per diluted share.
     Weighted Average Diluted Shares Outstanding:Diluted earnings per share were calculated based on an average number of diluted shares outstanding of 271 million and 280 million for the second quarters of 2010 and 2009 and 272 million and 282281 million for the quarterssix months ended JuneSeptember 30, 2009 and 2008. The decrease in the number of weighted average diluted shares outstanding primarily reflects a decrease in the number of common shares outstanding as a result of repurchased stock. Our earnings per share amounts have benefited from our share repurchases.stock, partially offset by share-based awards exercised.
Business Acquisitions
     During the first quarter of 2009, we acquired McQueary Brothers Drug Company (“McQueary Brothers”) of Springfield, Missouri for approximately $190 million. McQueary Brothers is a regional distributor of pharmaceutical, health and beauty products to independent and regional chain pharmacies in the Midwestern U.S. This acquisition expanded our existing U.S. pharmaceutical distribution business. The acquisition was funded with cash on hand. Approximately $126 million of the purchase price allocation was assigned to goodwill, which primarily reflects the expected future benefits from synergies to be realized upon integrating the business. During the first quarter of 2010, the acquisition accounting was completed. Financial results for McQueary Brothers have been included within our Distribution Solutions segment since the date of acquisition.
     Additional information regardingDuring the last two years, we also completed a number of other smaller acquisitions within both of our operating segments. Financial results for our business acquisitions have been included in our consolidated financial statements since their respective acquisition dates. Purchase prices for our business acquisitions have been allocated based on estimated fair values at the date of acquisition. Goodwill recognized for our business acquisitions is included in Financial Note 2, “Business Acquisitions,”generally not expected to be deductible for tax purposes. Pro forma results of operations for our business acquisitions have not been presented because the effects were not material to the accompanying condensed consolidated financial statements.

24


McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)
statements on either an individual or an aggregate basis.
New Accounting Developments
     New accounting pronouncements that we have recently adopted as well as those that have been recently issued but not yet adopted by us are included in Financial Note 1, “Significant Accounting Policies,” to the accompanying condensed consolidated financial statements.

27


McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)
Financial Condition, Liquidity and Capital Resources
     We expect our available cash generated from operations, together with our existing sources of liquidity from our accounts receivable sales facility and short-term borrowings under the revolving credit facility and commercial paper, will be sufficient to fund our long-term and short-term capital expenditures, working capital and other cash requirements. In addition, from time-to-time, we may access the long-term debt capital markets to discharge our other liabilities.
     Operating activities provided cash flow of $907$1,533 million and $314$548 million during the first quarterssix months of 2010 and 2009. Operating activities for 2010 primarily benefited from improved management of accounts receivable, inventory and drafts and accounts payable.payable as well as inventory. Operating activities for 2009 benefited from the accelerated receipt of $325 million ofreflect a decrease in drafts and accounts payable, as well as increases in our accounts receivable through our accounts receivable sales facility. Operating activities for 2009 also reflect an increase in our net financialand inventory (inventory, netbalances primarily associated with the timing of draftspayments and accounts payable) and accounts receivable primarilyreceipts, as a result of our revenue growth.well as inventory purchases. Cash flows from operations can be significantly impacted by factors such as the timing of receipts from customers inventory receipts and payments to vendors.
     Investing activities utilized cash of $86$192 million and $362$453 million during the first quarterssix months of 2010 and 2009. Investing activities include $189 million and $170 million in capital expenditures for property acquisitions and capitalized software in 2010 and 2009 include nilas well as $6 million and $242$320 million in 2010 and 2009 of cash paidpayments for business acquisitions. InActivity for 2009 we acquiredincludes the McQueary Brothers acquisition for approximately $190 million.
     Financing activities utilized cash of $303$267 million and $130$329 million duringin the first quarterssix months of 2010 and 2009. Financing activities for 2010 and 2009 include $298$322 million and $147$351 million in cash paid for stock repurchases.repurchases, partially offset by cash generated from stock issuances of $108 million and $65 million for 2010 and 2009.
     In April 2008, the Company’s Board of Directors (the “Board”) approved a plan to repurchase $1.0 billion of the Company’s common stock, of which $830 million remained available at March 31, 2009. During the second quarter and first quartersix months of 2010, we repurchased 71 million and 8 million shares for $275$24 million and $299 million, leaving $555$531 million available for future repurchases as of JuneSeptember 30, 2009. Stock repurchases may be made from time-to-time in open market or private transactions.
     AlthoughIn July 2008, the Board authorized the retirement of shares of the Company’s common stock that may be repurchased from time-to-time pursuant to its stock repurchase program. During the second quarter of 2009, all of the 4 million repurchased shares, which we purchased for $204 million, were formally retired by the Company. The retired shares constitute authorized but unissued shares. We elected to allocate any excess of share repurchase price over par value between additional paid-in capital and retained earnings. As such, $165 million was recorded as a decrease to retained earnings.
     On October 9, 2009, we paid $295 million into the escrow account related to the AWP Litigation settlement. See Financial Note 12, “Other Commitments and Contingent Liabilities,” for further information.
     We believe that our operating cash flow, financial assets and current access to capital and credit markets, as evidenced by our debt issuance in February 2009, including our existing credit and sales facilities, will give us the ability to meet our financing needs for the foreseeable future,future. However, there can be no assurance that continued or increased volatility and disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing.

2528


McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)
     Selected Measures of Liquidity and Capital Resources
         
  June 30, March 31,
(Dollars in millions) 2009 2009
 
Cash and cash equivalents $2,644  $2,109 
Working capital  3,121   3,065 
Debt, net of cash and cash equivalents  (133)  403 
Debt to capital ratio(1)
  28.6%  28.9%
Net debt to net capital employed(2)
  (2.2)%  6.1%
Return on stockholders’ equity(3)
  14.0%  13.2%
 
(1) Ratio is computed as total debt divided by total debt and stockholders’ equity.
         
  September 30, March 31,
(Dollars in millions) 2009 2009
 
Cash and cash equivalents $3,215  $2,109 
Working capital  3,510   3,065 
Debt, net of cash and cash equivalents  (703)  403 
Debt to capital ratio(1)
  27.2%  28.9%
Net debt to net capital employed(2)
  (11.7)  6.1 
Return on stockholders’ equity(3)
  13.4   13.2 
(2) Ratio is computed as total debt, net of cash and cash equivalents (“net debt”), divided by net debt and stockholders’ equity (“net capital employed”).
(1) Ratio is computed as total debt divided by total debt and stockholders’ equity.
(2) Ratio is computed as total debt, net of cash and cash equivalents (“net debt”), divided by net debt and stockholders’ equity (“net capital employed”).
(3) Ratio is computed as net income for the last four quarters, divided by a five-quarter average of stockholders’ equity.
     Working capital primarily includes cash and cash equivalents, receivables and inventories, net of drafts and accounts payable, deferred revenue and other liabilities. Our Distribution Solutions segment requires a substantial investment in working capital that is susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands. Inventory purchase activity is a function of sales activity and customer requirements. Consolidated working capital increased primarily as a result of a favorable increase in cash and cash equivalents, net of an increase in drafts and accounts payable.
     Our ratio of net debt to net capital employed decreased in 2010 primarily due to a higher cash and cash equivalents balances.balance.
Credit Resources
     We fund our working capital requirements primarily with cash and cash equivalents, our accounts receivable sales facility, short-term borrowings under the revolving credit facility and commercial paper.
Accounts Receivable Sales Facility
     In May 2009, we renewed our accounts receivable sales facility for an additional one year period under terms similar to those previously in place. The renewed facility will expire in May 2010. The May 2009 renewal increased the committed balance from $1.0 billion to $1.1 billion, although from time-to-time the available amount may be less than $1.1 billion based on concentration limits and receivable eligibility requirements.

29


McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)
     Through this facility, McKesson Corporation sells certain U.S. pharmaceutical trade accounts receivable on a non-recourse basis to a wholly-owned and consolidated subsidiary which then sells these receivables to a special purpose entity (“SPE”), which is a wholly-owned, bankruptcy-remote subsidiary of McKesson Corporation that is consolidated in our financial statements. This SPE then sells undivided interests in the receivables to third-party purchaser groups, each of which includes commercial paper conduits, (“Conduits”), which are special purpose legal entities administered by financial institutions.

26


McKESSON CORPORATION
FINANCIAL REVIEW (CONTINUED)
(UNAUDITED)
     Additional information regarding our accounts receivable sales facility is included in Financial Note 7,8, “Financing Activities,” to the accompanying condensed consolidated financial statements.
Revolving Credit Facility
     We have a syndicated $1.3 billion five-year, senior unsecured revolving credit facility which expires in June 2012. Borrowings under this credit facility bear interest based upon either a Prime rate or the London Interbank Offering Rate. Total borrowings under this facility were nil and $62$189 million for the first quarterssix months of 2010 and 2009. As of JuneSeptember 30, 2009 and March 31, 2009, there were no amounts outstanding under this facility.
Commercial Paper
     We issued and repaid commercial paper of nil and $496 million in commercial paperapproximately $3.3 billion for the first quarterssix months of 2010 and 2009. There were no commercial paper issuances outstanding at JuneSeptember 30, 2009 and March 31, 2009.
Long-Term Debt
     On February 12, 2009, we issued 6.50% notes due February 15, 2014 (the “2014 Notes”) in an aggregate principal amount of $350 million and 7.50% notes due February 15, 2019 (the “2019 Notes”) in an aggregate principal amount of $350 million. Interest is payable on February 15 and August 15 of each year beginning on August 15, 2009. The 2014 Notes will mature on February 15, 2014 and the 2019 Notes will mature on February 15, 2019. We utilized net proceeds, after offering expenses, of $693 million from the issuance of the 2014 Notes and 2019 Notes for general corporate purposes.
Debt Covenants
     Our various borrowing facilities and long-term debt are subject to certain covenants. Our principal debt covenant is our debt to capital ratio, which cannot exceed 56.5%. If we exceed this ratio, repayment of debt outstanding under the revolving credit facility and $215 million of term debt could be accelerated. As of JuneSeptember 30, 2009, this ratio was 28.6%27.2% and we were in compliance with our other financial covenants. A reduction in our credit ratings or the lack of compliance with our covenants could negatively impact our ability to finance operations through our credit facilities or issue additional debt at the interest rates then currently available.
     Funds necessary for future debt maturities and our other cash requirements are expected to be met by existing cash balances, cash flowsflow from operations, existing credit sources and other capital market transactions.

2730


McKESSON CORPORATION
FINANCIAL REVIEW (CONCLUDED)
(UNAUDITED)
FACTORS AFFECTING FORWARD-LOOKING STATEMENTS
     This Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 2 of Part I of this report, contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as amended. Some of these statements can be identified by use of forward-looking words such as “believes,” “expects,” “anticipates,” “may,” “will,” “should,” “seeks,” “approximates,” “intends,” “plans,” or “estimates,” or the negative of these words, or other comparable terminology. The discussion of financial trends, strategy, plans or intentions may also include forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. Although it is not possible to predict or identify all such risks and uncertainties, they may include, but are not limited to, the following factors. The reader should not consider this list to be a complete statement of all potential risks and uncertainties:
§ material adverse resolution of pending legal proceedings;
 
§ changes in the U.S. healthcare industry and regulatory environment;
 
§ competition;
 
§ the frequency or rate of branded drug price inflation and generic drug price deflation;
 
§ substantial defaults in payments or a material reduction in purchases by, or loss of, a large customer;
 
§ implementation delay, malfunction or failure of internal information systems;
 
§ the adequacy of insurance to cover property loss or liability claims;
 
§ the Company’s failure to attract and retain customers for its software products and solutions due to integration and implementation challenges, or due to an inability to keep pace with technological advances;
 
§ loss of third party licenses for technology incorporated into the Company’s products and solutions;
 
§ the Company’s proprietary products and services may not be adequately protected and its products and solutions may infringe on the rights of others;
 
§ failure of our technology products and solutions to conform to specifications;
 
§ disaster or other event causing interruption of customer access to the data residing in our service centers;
 
§ increased costs or product delays required to comply with existing and changing regulations applicable to our businesses and products;
 
§ changes in government regulations relating to sensitive personal information and to format and data content standards;
 
§ the delay or extension of our sales or implementation cycles for external software products;
 
§ changes in circumstances that could impair our goodwill or intangible assets;
 
§ foreign currency fluctuations or disruptions to our foreign operations;
 
§ new or revised tax legislation or challenges to our tax positions;
 
§ the Company’s ability to successfully identify, consummate and integrate strategic acquisitions;
 
§ continued volatility and disruption to the global capital and credit markets;
§failure to adequately prepare for and accurately assess the scope, duration or financial impact of public health issues on our operations, particularly the Company’s current H1N1 flu vaccine distribution effort with the Centers for Disease Control and Prevention, whether occurring in the United States or abroad; and
 
§ changes in accounting standards issued by the Financial Accounting Standards Board or other standard setting bodies.
     These and other risks and uncertainties are described herein and in other information contained in our publicly available Securities and Exchange Commission filings and press releases. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date such statements were first made. Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to these forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events.

2831


McKESSON CORPORATION
Item 3.Quantitative and Qualitative Disclosures about Market Risk
Item 3. Quantitative and Qualitative Disclosures about Market Risk
     We believe there has been no material change in our exposure to risks associated with fluctuations in interest and foreign currency exchange rates discussedas disclosed in our 2009 Annual Report on Form 10-K.
Item 4.Controls and Procedures
Item 4. Controls and Procedures
     Our Chief Executive Officer and our Chief Financial Officer, with the participation of other members of the Company’s management, have evaluated the effectiveness of the Company’s “disclosure controls and procedures” (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”)) as of the end of the period covered by this quarterly report, and our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective based on their evaluation of these controls and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15.
     There were no changes in our “internal control over financial reporting” (as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1.Legal Proceedings
Item 1. Legal Proceedings
     See Financial Note 11,12, “Other Commitments and Contingent Liabilities,” of our unaudited condensed consolidated financial statements contained in Part I of this Quarterly Report on Form 10-Q.
Item 1A.Risk Factors
Item 1A. Risk Factors
     There have been no material changes from the risk factors disclosed in Part 1, Item 1A, of our 2009 Annual Report on Form 10-K.10-K except as follows:
Our future results could be materially affected by a number of public health issues, such as the potential H1N1 flu pandemic, whether occurring in the United States or abroad.
     Public health issues, such as a potential H1N1 flu pandemic, whether occurring in the United States or abroad, could disrupt our operations, disrupt the operations of suppliers or customers or have a broader adverse impact on consumer spending and confidence levels that would negatively affect our suppliers and customers. We have developed contingency plans to address infectious disease scenarios and the potential impact on our operations and will continue to update these plans as necessary. However, there can be no assurance given that these plans will be effective in eliminating the negative impact of any such diseases on the Company’s operating results. We may be required to suspend operations in some or all of our locations, which could have a material adverse impact on our business, financial condition and results of operations.
     On August 10, 2009, we announced that the Company’s current partnership with the Centers for Disease Control and Prevention (“CDC”) had been expanded to include preparations for H1N1 flu vaccine distribution. The H1N1 vaccine distribution effort includes the centralized distribution of the H1N1 flu vaccine and ancillary medical-surgical supplies to as many as 150,000 sites across the country making it one of the largest public health initiatives in the CDC’s history. The Company is managing its part of the H1N1 flu vaccine initiative, which includes distribution of the vaccine to sites designated by state public health departments across the country.

32


McKESSON CORPORATION
     Currently, we have a contract with the CDC for the distribution of its public-sector purchased adult and pediatric vaccines, including those distributed through the Vaccines for Children Program (“VFC”). While a number of important steps to expand our current relationship with the CDC have been accomplished, the CDC and the Company have not yet completed all necessary modifications to the Company’s existing VFC agreement to encompass the H1N1 vaccine distribution program in its entirety. For example, the parties have not yet completed a final modification that will govern the pricing and financial impact of our H1N1 vaccine distribution effort. Moreover, given the unprecedented nature and scope of the H1N1 vaccine distribution program, it is currently unknown how many doses of the vaccine will be made available by vaccine manufacturers or how many doses will be shipped by the Company to sites designated by state public health departments over the life of the program. Due to the above described uncertainties, some of which may continue throughout the remainder of 2010, the Company’s future results of operations and financial condition may be subject to considerable variability. In arriving at the Company’s updated 2010 outlook, which was publicly announced by a Current Report on Form 8-K furnished to the Securities and Exchange Commission on October 27, 2009, we considered a broad array of possible outcomes with regard to these program variables. To the degree we failed to adequately prepare for and accurately assess the scope, duration or financial impact of public health issues on our operations, particularly the Company’s current H1N1 flu vaccine distribution effort, our publicly reported results of operations and financial condition may be substantially more or less than that projected for 2010.
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
     The following table provides information on the Company’s share repurchases during the firstsecond quarter of 2010.
                 
  Share Repurchases(1)
     Approximate
          Total Number of Dollar Value of
          Shares Purchased Shares that May
  Total Number of     As Part of Publicly Yet Be Purchased
  Shares Average Price Paid Announced Under the
(In millions, except price per share) Purchased(2) (3) Per Share Program Program(1)
 
April 1, 2009 - April 30, 2009    $     $830 
May 1, 2009 - May 31, 2009  3   39.92   3   710 
June 1, 2009 - June 30, 2009  4   41.31   4   555 
                 
Total  7   40.69   7   555 
 
                 
  Share Repurchases(1)
              Approximate
          Total Number of Dollar Value of
          Shares Purchased Shares that May
  Total Number of     As Part of Publicly Yet Be Purchased
  Shares Average Price Paid Announced Under the
(In millions, except price per share) Purchased(2) (3) Per Share Program Programs(1)
July 1, 2009 - July 31, 2009    $     $555 
August 1, 2009 — August 31, 2009  1   53.23   1   531 
September 1, 2009 — September 30, 2009           531 
                 
Total  1   53.23   1   531 
 
(1)
(1) This table does not include shares tendered to satisfy the exercise price in connection with cashless exercises of employee stock options or shares tendered to satisfy tax withholding obligations in connection with employee equity awards.
 
(2) All of the shares purchased were part of the publicly announced share repurchase program.
 
(3) The number of shares purchased reflects rounding adjustments.
Item 3. Defaults Upon Senior Securities
     None

2933


McKESSON CORPORATION
Item 3.Defaults Upon Senior Securities
Item 4. Submission of Matters to a Vote of Security Holders
     NoneThe Company’s Annual Meeting of Stockholders was held on July 22, 2009. The following matters were voted upon at the meeting and the stockholder votes on each such matter are briefly described below.*
     The Board of Directors’ nominees for directors as listed in the proxy statement were each elected to serve a one-year term. The votes were as follows: †
             
  Votes For Votes Against Votes Abstained
Andy D. Bryant  233,307,217   5,217,677   523,612 
Wayne A. Budd  231,187,517   7,353,131   507,858 
John H. Hammergren  228,915,395   9,718,439   414,672 
Alton F. Irby III  197,732,220   40,754,966   561,020 
M. Christine Jacobs  200,034,370   38,502,535   511,601 
Marie L. Knowles  233,292,309   5,267,712   488,485 
David M. Lawrence M.D.  200,166,570   38,468,130   413,506 
Edward A. Mueller  207,260,355   31,372,885   415,266 
Jane E. Shaw  229,295,217   9,327,059   426,230 
     There were no broker non-votes with respect to the Board of Directors’ nominees for directors listed above.
     The proposal to amend the Company’s 2005 Stock Plan to increase the number of shares of common stock reserved for issuance under the plan by 14,500,000 was approved, having received the following votes: ††
       
Votes For Votes Against Votes Abstained Broker Non-Votes
177,314,610 37,766,601 242,622 23,724,673
     The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending March 31, 2010 was ratified, having received the following votes: ††
     
Votes For Votes Against Votes Abstained
236,513,833 2,194,748 339,925
     There were no broker non-votes with respect to the ratification of the appointment of Deloitte & Touche LLP described above.
     The stockholder proposal on executive stock retention for two years beyond retirement was not approved, having received the following votes: ††
       
Votes For Votes Against Votes Abstained Broker Non-Votes
65,550,355 148,968,219 805,260 23,724,672
     The stockholder proposal on executive benefits provided upon death while in service was not approved, having received the following votes: ††
       
Votes For Votes Against Votes Abstained Broker Non-Votes
107,598,016 101,659,126 6,066,692 23,724,672
Item 4.* SubmissionWith regard to the election of Mattersdirectors, the number of votes for, against and abstained, when totaled, may not be the same for every nominee. With regard to the proposals for which there were broker non-votes, the number of such non-votes may not be the same for every proposal.
Under the Company’s majority voting standard, the election of a Votenominee required that the nominee receive a majority of Security Holdersthe votes cast (that is, the number of votes cast “for” each nominee had to exceed the number of votes cast “against” such nominee). Therefore, broker non-votes and abstentions were required to be disregarded and had no effect on the vote results.
††Approval of this proposal required the affirmative vote of a majority of the shares present, in person or by proxy, and entitled to vote on the proposal at the meeting. Therefore, abstentions, which represented shares present and entitled to vote, had the same effect as a vote against the proposal. Broker non-votes were required to be disregarded and had no effect on the vote results.

34


McKESSON CORPORATION
Item 5. Other Information
     None
Item 5.Other Information
     None
Item 6.Item 6. Exhibits
Exhibit No.
   
Exhibit
NumberDescription
10.1 Second AmendedMcKesson Corporation 2005 Stock Plan, as amended and Restated Receivables Purchase Agreement, dated as of May 20, 2009, among the Company, as servicer, CGSF Funding Corporation, as seller, the several conduit purchasers from time to time party to the Agreement, the several committed purchasers from time to time party to the Agreement, the several managing agents from time to time party to the Agreement, and JPMorgan Chase Bank, N.A., as collateral agent.restated on July 22, 2009.
   
31.1 Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
31.2 Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
32 Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101* The following materials from the McKesson Corporation Quarterly Report on Form 10-Q for the quarter ended JuneSeptember 30, 2009, formatted in Extensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Operations, (ii) Condensed Consolidated Balance Sheets, (iii) Condensed Consolidated Statements of Cash Flows, and (iv) related notes, tagged as blocks of text.
 
* Furnished herewith.
SIGNATURES
     Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
     
 McKesson Corporation
 
 
Dated: July 28,October 27, 2009 /s/ Jeffrey C. Campbell   
 Jeffrey C. Campbell  
 Executive Vice President and Chief Financial Officer  
 
   
 /s/ Nigel A. Rees   
 Nigel A. Rees  
 Vice President and Controller  
 

3035